Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Liver Diseases

  Free Subscription


Articles published in Hepatology

Retrieve available abstracts of 651 articles:
HTML format
Text format



Single Articles


    February 2012
  1. D'AMICO G , Tine F
    Long-term low-dose maintenance pegylated interferon may prevent decompensation in cirrhotic patients with portal hypertension: Are we there yet?
    Hepatology. 2012;55:642-4.
    PubMed     Text format     Related articles   



    January 2012
  2. HUANG HC , Wang SS, Hsin IF, Chang CC, et al
    Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.
    Hepatology. 2012 Jan 30. doi: 10.1002/hep.25625.
    PubMed     Text format     Related articles    Abstract available



  3. LO GH
    The role of imaging techniques in clinical decision making for the management of hepatocellular carcinoma.
    Hepatology. 2012 Jan 30. doi: 10.1002/hep.25618.
    PubMed     Text format     Related articles   



  4. TANAKA N , Matsubara T, Krausz KW, Patterson AD, et al
    Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis.
    Hepatology. 2012 Jan 30. doi: 10.1002/hep.25630.
    PubMed     Text format     Related articles    Abstract available



  5. MERCHANTE N , Rivero-Juarez A, Tellez F, Merino D, et al
    Liver stiffness predicts clinical outcome in HIV/HCV-coinfected patients with compensated liver cirrhosis.
    Hepatology. 2012 Jan 25. doi: 10.1002/hep.25616.
    PubMed     Text format     Related articles    Abstract available



  6. LAKNER AM , Steuerwald NM, Walling TL, Ghosh S, et al
    Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
    Hepatology. 2012 Jan 25. doi: 10.1002/hep.25613.
    PubMed     Text format     Related articles    Abstract available



  7. ZHOU L , Xu L, Ye J, Li D, et al
    Cidea promotes hepatic steatosis by sensing dietary fatty acids.
    Hepatology. 2012 Jan 25. doi: 10.1002/hep.25611.
    PubMed     Text format     Related articles    Abstract available



  8. WANG QB , Zhu H, Liu HL, Zhang B, et al
    Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis.
    Hepatology. 2012 Jan 25. doi: 10.1002/hep.25610.
    PubMed     Text format     Related articles    Abstract available



  9. LEE J , Mi Seok S, Yu P, Kim K, et al
    Genomic analysis of hepatic farnesoid X receptor (FXR) binding sites reveals altered binding in obesity and direct gene repression by FXR.
    Hepatology. 2012 Jan 25. doi: 10.1002/hep.25609.
    PubMed     Text format     Related articles    Abstract available



  10. FUJIWARA K , Yokosuka O
    Frequent detection of IgM anti-herpes simplex viral antibody in patients with primary biliary cirrhosis.
    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25597.
    PubMed     Text format     Related articles   



  11. RAMANI K , Lauda Tomasi M
    Transcriptional regulation of methionine adenosyltransferase 2A by peroxisome proliferator-activated receptors in rat hepatic stellate cells.
    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25594.
    PubMed     Text format     Related articles    Abstract available



  12. UN K , Kawakami S, Yoshida M, Higuchi Y, et al
    Efficient suppression of murine ICAM-1 using ultrasound-responsive and mannose-modified lipoplexes inhibits acute hepatic inflammation.
    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25607.
    PubMed     Text format     Related articles    Abstract available



  13. D'AMBROSIO R , Aghemo A, Grazia Rumi M, Ronchi G, et al
    A morphometric and immunohistochemical study to assess the benefit of an svr in hcv cirrhotic patients.
    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25606.
    PubMed     Text format     Related articles    Abstract available



  14. PORTINCASA P , Wang DQ
    Intestinal absorption, hepatic synthesis, and biliary secretion of cholesterol: Where are we for cholesterol gallstone formation?
    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25604.
    PubMed     Text format     Related articles   



  15. TOSO C , Dupuis-Lozeron E, Majno P, Berney T, et al
    A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list.
    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25603.
    PubMed     Text format     Related articles    Abstract available



  16. FUCHS C , Claudel T, Kumari P, Haemmerle G, et al
    Absence of adipose triglyceride lipase protects from hepatic ER stress.
    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25601.
    PubMed     Text format     Related articles    Abstract available



  17. EVERT M , Calvisi DF, Evert K, De Murtas V, et al
    AKT/mTOR activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis.
    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25600.
    PubMed     Text format     Related articles    Abstract available



  18. CORPECHOT C , Carrat F, Poujol-Robert A, Gaouar F, et al
    Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis.
    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25599.
    PubMed     Text format     Related articles    Abstract available



  19. HAYASHI H , Inamura K, Aida K, Naoi S, et al
    AP2 mediates BSEP internalization and modulates its hepatocanalicular expression and transport function.
    Hepatology. 2012 Jan 19. doi: 10.1002/hep.25591.
    PubMed     Text format     Related articles    Abstract available



  20. LIU M , Chen LL, Chan TH, Wang J, et al
    Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma.
    Hepatology. 2012 Jan 19. doi: 10.1002/hep.25584.
    PubMed     Text format     Related articles    Abstract available



  21. ROWE I , Armstrong M, Parker R, Houlihan D, et al
    Informed consent in surveillance for hepatocellular carcinoma in patients with cirrhosis.
    Hepatology. 2012 Jan 19. doi: 10.1002/hep.25588.
    PubMed     Text format     Related articles   



  22. YAN W , Chang Y, Liang X, Cardinal JS, et al
    High mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases.
    Hepatology. 2012 Jan 11. doi: 10.1002/hep.25572.
    PubMed     Text format     Related articles    Abstract available



  23. SEOK JY , Na DC, Woo HG, Roncalli M, et al
    A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and EMT.
    Hepatology. 2012 Jan 11. doi: 10.1002/hep.25570.
    PubMed     Text format     Related articles    Abstract available



  24. SHEN J , Wang S, Zhang YJ, Kappil M, et al
    Genome-wide DNA methylation profiles in hepatocellular carcinoma.
    Hepatology. 2012 Jan 11. doi: 10.1002/hep.25569.
    PubMed     Text format     Related articles    Abstract available



  25. AMODIO P , Montagnese S, Merkel C
    Attention: Minimal hepatic encephalopathy and road accidents.
    Hepatology. 2012 Jan 11. doi: 10.1002/hep.25583.
    PubMed     Text format     Related articles   



  26. GRISE F , Sena S, Bidaud-Meynard A, Baud J, et al
    Rnd3/RhoE is down-regulated in hepatocellular carcinoma and controls cellular invasion.
    Hepatology. 2012 Jan 11. doi: 10.1002/hep.25568.
    PubMed     Text format     Related articles    Abstract available



  27. HASSING HC , Mooij H, Guo S, Monia BP, et al
    Inhibition of hepatic Sulf2 in vivo: A novel strategy to correct diabetic dyslipidemia.
    Hepatology. 2012 Jan 11. doi: 10.1002/hep.25580.
    PubMed     Text format     Related articles    Abstract available



  28. FANG YX , Xue JL, Shen Q, Chen J, et al
    miR-7 inhibits tumor growth and metastasis by targeting the PI3K/AKT pathway in hepatocellular carcinoma.
    Hepatology. 2012 Jan 11. doi: 10.1002/hep.25576.
    PubMed     Text format     Related articles    Abstract available



  29. SWENSON ES
    Direct conversion of mouse fibroblasts to hepatocyte-like cells using forced expression of endodermal transcription factors.
    Hepatology. 2012;55:316-8.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  30. LIU G , Jiang S, Wang C, Jiang W, et al
    Zinc finger transcription factor 191, directly binding to beta-catenin promoter, promotes cell proliferation of hepatocellular carcinoma.
    Hepatology. 2011 Dec 27. doi: 10.1002/hep.25564.
    PubMed     Text format     Related articles    Abstract available



  31. HEATHCOTE EJ
    Clinical trials and their translation in hepatology: Past, present and future.
    Hepatology. 2011 Dec 27. doi: 10.1002/hep.25557.
    PubMed     Text format     Related articles   



  32. SORIANO G , Roman E, Cordoba J, Torrens M, et al
    Cognitive dysfunction in cirrhosis is associated with falls. A prospective study.
    Hepatology. 2011 Dec 27. doi: 10.1002/hep.25554.
    PubMed     Text format     Related articles    Abstract available



  33. ZHANG JX , Li DQ, He AR, Motwani M, et al
    Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (ADP-ribose) polymerases.
    Hepatology. 2011 Dec 27. doi: 10.1002/hep.25566.
    PubMed     Text format     Related articles    Abstract available



  34. SULLIVAN S , Kirk EP, Mittendorfer B, Patterson BW, et al
    Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.
    Hepatology. 2011 Dec 24. doi: 10.1002/hep.25548.
    PubMed     Text format     Related articles    Abstract available



  35. SINGAL AK , Bashar H, Anand BS, Jampana SC, et al
    Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: Exploratory analysis from UNOS database.
    Hepatology. 2011 Dec 24. doi: 10.1002/hep.25544.
    PubMed     Text format     Related articles    Abstract available



  36. REDDY SK , Steel JL, Chen HW, Demateo DJ, et al
    Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.
    Hepatology. 2011 Dec 20. doi: 10.1002/hep.25536.
    PubMed     Text format     Related articles    Abstract available



  37. YANG YY , Tsai TH, Huang YT, Lee TY, et al
    Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinaemia in nonalcoholic steatohepatitis-cirrhotic rats.
    Hepatology. 2011 Dec 20. doi: 10.1002/hep.25534.
    PubMed     Text format     Related articles    Abstract available



  38. FERNANDEZ J , Acevedo J, Castro M, Garcia O, et al
    Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study.
    Hepatology. 2011 Dec 20. doi: 10.1002/hep.25532.
    PubMed     Text format     Related articles    Abstract available



  39. KIM EJ , Yoon YS, Hong S, Son HY, et al
    RORalpha-induced activation of AMP-activated protein kinase results in attenuation of hepatic steatosis.
    Hepatology. 2011 Dec 20. doi: 10.1002/hep.25529.
    PubMed     Text format     Related articles    Abstract available



  40. CHOI S , Diehl AM
    After Goodbye? Dead hepatocytes as a biomarker for fibrosis and steatohepatitis.
    Hepatology. 2011 Dec 20. doi: 10.1002/hep.25540.
    PubMed     Text format     Related articles   



  41. TREPO E , Guyot E, Ganne-Carrie N, Degre D, et al
    PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosi.
    Hepatology. 2011 Dec 12. doi: 10.1002/hep.25518.
    PubMed     Text format     Related articles   



  42. YILMAZ Y , Kurt R
    Is M65 really better than M30 as a biomarker of hepatic fibrosis?
    Hepatology. 2011 Dec 12. doi: 10.1002/hep.25520.
    PubMed     Text format     Related articles   



  43. WONG CM , Wong CC, Lee JM, Fan DN, et al
    Sequential alterations of miRNA expression in hepatocellular carcinoma development and venous metastasis.
    Hepatology. 2011 Dec 2. doi: 10.1002/hep.25512.
    PubMed     Text format     Related articles    Abstract available



  44. BAJAJ JS , Pinkerton SD, Sanyal AJ, Heuman DM, et al
    Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: A cost-effectiveness analysis.
    Hepatology. 2011 Dec 2. doi: 10.1002/hep.25507.
    PubMed     Text format     Related articles    Abstract available



  45. VALENTI L , Alisi A, Nobili V
    I148M PNPLA3 variant and progressive liver disease: A new paradigm in hepatology.
    Hepatology. 2011 Dec 2. doi: 10.1002/hep.25506.
    PubMed     Text format     Related articles    Abstract available



  46. YING Q , Liang L, Guo W, Zha R, et al
    Hypoxia-inducible MicroRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma.
    Hepatology. 2011;54:2064-75.
    PubMed     Text format     Related articles    Abstract available



  47. TRINCHET JC , Chaffaut C, Bourcier V, Degos F, et al
    Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities.
    Hepatology. 2011;54:1987-1997.
    PubMed     Text format     Related articles    Abstract available




  48. 2011 Hepatology referees (volumes 53 and 54).
    Hepatology. 2011;54:I-V.
    PubMed     Text format     Related articles   



  49. LECLERCQ IA , Van Rooyen DM, Farrell GC
    Hepatic endoplasmic reticulum stress in obesity: Deeper insights into processes, but are they relevant to nonalcoholic steatohepatitis?
    Hepatology. 2011;54:2261-6.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  50. KHATUN I , Zeissig S, Iqbal J, Wang M, et al
    The phospholipid transfer activity of MTP produces apoB-lipoproteins and reduces hepatosteatosis while maintaining low plasma lipids.
    Hepatology. 2011 Nov 26. doi: 10.1002/hep.25504.
    PubMed     Text format     Related articles    Abstract available



  51. KIM YC , Park MS
    Distal common bile duct (CBD) metastasis from hepatocelluar carcinoma (HCC).
    Hepatology. 2011 Nov 26. doi: 10.1002/hep.25502.
    PubMed     Text format     Related articles   



  52. LIU L , Yannam GR, Nishikawa T, Yamamoto T, et al
    The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis.
    Hepatology. 2011 Nov 23. doi: 10.1002/hep.24815.
    PubMed     Text format     Related articles    Abstract available



  53. SENTHILNATHAN S , Memon K, Lewandowski RJ, Kulik L, et al
    Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated by locoregional therapies: Analyzing patterns of progression in 285 patients.
    Hepatology. 2011 Nov 23. doi: 10.1002/hep.24812.
    PubMed     Text format     Related articles    Abstract available



  54. SETHASINE S , Jain D, Groszmann RJ, Garcia-Tsao G, et al
    Quantitative histological-hemodynamic correlations in cirrhosis.
    Hepatology. 2011 Nov 23. doi: 10.1002/hep.24805.
    PubMed     Text format     Related articles    Abstract available



  55. CHAI J , He Y, Cai SY, Jiang Z, et al
    Elevated hepatic MRP3/ABCC3 expression in human obstructive cholestasis is mediated through TNFalpha and JNK/SAPK signaling pathway.
    Hepatology. 2011 Nov 22. doi: 10.1002/hep.24801.
    PubMed     Text format     Related articles    Abstract available



  56. HU L , Zhai X, Liu J, Chu M, et al
    Genetic variants in HLA-DP/DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
    Hepatology. 2011 Nov 22. doi: 10.1002/hep.24799.
    PubMed     Text format     Related articles    Abstract available



  57. KIM SM , Leem SH, Chu IS, Park YY, et al
    65-gene-based risk score classifier predicts overall survival in hepatocellular carcinoma.
    Hepatology. 2011 Nov 22. doi: 10.1002/hep.24813.
    PubMed     Text format     Related articles    Abstract available



  58. ASRANI SK , Larusso NF
    Fibrolamellar hepatocellular carcinoma presenting with Budd Chiari syndrome, right atrial thrombus and pulmonary emboli.
    Hepatology. 2011 Nov 22. doi: 10.1002/hep.24811.
    PubMed     Text format     Related articles   



  59. ROHR-UDILOVA N , Sieghart W, Eferl R, Stoiber D, et al
    Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma.
    Hepatology. 2011 Nov 22. doi: 10.1002/hep.24808.
    PubMed     Text format     Related articles    Abstract available



  60. KNIGHT V , Tchongue J, Lourensz D, Tipping P, et al
    Protease-activated receptor 2 promotes experimental liver fibrosis and activates human hepatic stellate cells.
    Hepatology. 2011 Nov 16. doi: 10.1002/hep.24784.
    PubMed     Text format     Related articles    Abstract available



  61. ZHANG C , Wang G, Zheng Z, Maddipati KR, et al
    ER-tethered transcription factor crebh regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress.
    Hepatology. 2011 Nov 16. doi: 10.1002/hep.24783.
    PubMed     Text format     Related articles    Abstract available



  62. LING J , Chaba T, Zhu LF, Jacobs RL, et al
    Hepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in mice.
    Hepatology. 2011 Nov 16. doi: 10.1002/hep.24782.
    PubMed     Text format     Related articles    Abstract available



  63. MOLHO-PESSACH V , Rios JJ, Xing C, Setchell KD, et al
    Homozygosity mapping identifies a bile acid biosynthetic defect in an adult with cirrhosis of unknown etiology.
    Hepatology. 2011 Nov 16. doi: 10.1002/hep.24781.
    PubMed     Text format     Related articles    Abstract available



  64. IAVARONE M , Sangiovanni A
    Letter to the Editor: Korosh Khalili, Tae Kyoung Kim, Hyun-Jung Jang, Leyla Kochak Yazdi, Maha Guindi and Morris Sherman. Indeterminate 1-2 cm nodules found on hepatocellular carcinoma surveillance: Biopsy for all, some, or none? Accepted manuscript o
    Hepatology. 2011 Nov 16. doi: 10.1002/hep.24780.
    PubMed     Text format     Related articles   



  65. ISHIKAWA T , Factor VM, Marquardt JU, Raggi C, et al
    Hepatocyte growth factor (HGF) /c-Met signaling is required for stem cell mediated liver regeneration.
    Hepatology. 2011 Nov 16. doi: 10.1002/hep.24796.
    PubMed     Text format     Related articles    Abstract available



  66. JOHNSTON R , Dolman G, Aithal G
    To feed or what to feed in cirrhosis?
    Hepatology. 2011 Nov 16. doi: 10.1002/hep.24771.
    PubMed     Text format     Related articles   



  67. TURATI F , Edefonti V, Talamini R, Ferraroni M, et al
    Family history of liver cancer and hepatocellular carcinoma.
    Hepatology. 2011 Nov 16. doi: 10.1002/hep.24794.
    PubMed     Text format     Related articles    Abstract available



  68. BECHMANN LP , Gastaldelli A, Vetter D, Patman GL, et al
    Glucokinase links kruppel-like factor 6 to the regulation of hepatic insulin sensitivity in non-alcoholic fatty liver disease.
    Hepatology. 2011 Nov 16. doi: 10.1002/hep.24793.
    PubMed     Text format     Related articles    Abstract available



  69. YANG MD , Chiang YM, Higashiyama R, Asahina K, et al
    Rosmarinic acid and baicalin epigenetically de-repress Ppargamma in hepatic stellate cells for their anti-fibrotic effect.
    Hepatology. 2011 Nov 16. doi: 10.1002/hep.24792.
    PubMed     Text format     Related articles    Abstract available



  70. CHEN YF , Tseng CY, Wang HW, Kuo HC, et al
    Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol.
    Hepatology. 2011 Nov 16. doi: 10.1002/hep.24790.
    PubMed     Text format     Related articles    Abstract available



  71. TELTSCHIK Z , Wiest R, Beisner J, Nuding S, et al
    Intestinal bacterial translocation in cirrhotic rats is related to compromised paneth cell antimicrobial host defence.
    Hepatology. 2011 Nov 16. doi: 10.1002/hep.24789.
    PubMed     Text format     Related articles    Abstract available



  72. JIA YL , Shi L, Zhou JN, Fu CJ, et al
    Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis.
    Hepatology. 2011;54:1808-18.
    PubMed     Text format     Related articles    Abstract available



  73. KIM H , Choi GH, Na DC, Ahn EY, et al
    Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
    Hepatology. 2011;54:1707-17.
    PubMed     Text format     Related articles    Abstract available



  74. GHANY MG , Kim HY, Stoddard A, Wright EC, et al
    Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial.
    Hepatology. 2011;54:1527-1537.
    PubMed     Text format     Related articles    Abstract available



  75. STERLING RK , Sanyal AJ
    Pentoxifylline for steatohepatitis: Magic bullet or smoking gun?
    Hepatology. 2011;54:1496-9.
    PubMed     Text format     Related articles   



  76. STARKEY LEWIS PJ , Dear J, Platt V, Simpson KJ, et al
    Circulating microRNAs as potential markers of human drug-induced liver injury.
    Hepatology. 2011;54:1767-76.
    PubMed     Text format     Related articles    Abstract available



  77. ALISI A , Carsetti R, Nobili V
    Pathogen- or damage-associated molecular patterns during nonalcoholic fatty liver disease development.
    Hepatology. 2011;54:1500-2.
    PubMed     Text format     Related articles   



  78. GOUW AS , Clouston AD, Theise ND
    Ductular reactions in human liver: diversity at the interface.
    Hepatology. 2011;54:1853-63.
    PubMed     Text format     Related articles    Abstract available



  79. COREY KE , Chalasani N
    Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?
    Hepatology. 2011;54:1503-5.
    PubMed     Text format     Related articles   



  80. FANG JH , Zhou HC, Zeng C, Yang J, et al
    MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression.
    Hepatology. 2011;54:1729-40.
    PubMed     Text format     Related articles    Abstract available



  81. GAO Q , Wang XY, Zhou J, Fan J, et al
    Cell line misidentification: the case of the Chang liver cell line.
    Hepatology. 2011;54:1894-5.
    PubMed     Text format     Related articles   



    October 2011
  82. TAKAHASHI T , Miura T, Nakamura J, Yamada S, et al
    Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis.
    Hepatology. 2011 Oct 26. doi: 10.1002/hep.24757.
    PubMed     Text format     Related articles    Abstract available



  83. SAKAI N , Van Sweringen HL, Schuster R, Blanchard J, et al
    Receptor activator of NF-kappaB ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice.
    Hepatology. 2011 Oct 26. doi: 10.1002/hep.24756.
    PubMed     Text format     Related articles    Abstract available



  84. HEYMANN F , Hammerich L, Storch D, Bartneck M, et al
    Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor CCR8.
    Hepatology. 2011 Oct 26. doi: 10.1002/hep.24764.
    PubMed     Text format     Related articles    Abstract available



  85. SCHOUTEN J , Janssen H
    Reply to letter to the editor on idiopathic non cirrhotic portal hypertension.
    Hepatology. 2011 Oct 26. doi: 10.1002/hep.24753.
    PubMed     Text format     Related articles   



  86. LI K , Li NL, Wei D, Pfeffer SR, et al
    Activation of chemokine and inflammatory cytokine response in HCV-infected hepatocytes depends on TLR3 sensing of HCV dsRNA intermediates.
    Hepatology. 2011 Oct 26. doi: 10.1002/hep.24763.
    PubMed     Text format     Related articles    Abstract available



  87. KALAMBOKIS GN , Tsianos EV
    Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis.
    Hepatology. 2011 Oct 26. doi: 10.1002/hep.24751.
    PubMed     Text format     Related articles   



  88. GOEL A , Ramakrishna B, Madhu K, Zachariah U, et al
    Idiopathic non cirrhotic intrahepatic portal hypertension is an on-going problem in India.
    Hepatology. 2011 Oct 26. doi: 10.1002/hep.24750.
    PubMed     Text format     Related articles   



  89. GROSSE B , Cassio D, Yousef N, Bernardo C, et al
    Claudin-1 involved in neonatal ichthyosis - sclerosing cholangitis syndrome, regulates hepatic paracellular permeability.
    Hepatology. 2011 Oct 26. doi: 10.1002/hep.24761.
    PubMed     Text format     Related articles    Abstract available



  90. TSUDA M , Moritoki Y, Lian ZX, Zhang W, et al
    Biochemical and immunologic effects of rituximab in primary biliary cirrhosis patients with an incomplete response to ursodeoxycholic acid.
    Hepatology. 2011 Oct 17. doi: 10.1002/hep.24748.
    PubMed     Text format     Related articles    Abstract available



  91. RATZIU V , Sheikh MY, Sanyal AJ, Lim JK, et al
    A Phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis.
    Hepatology. 2011 Oct 17. doi: 10.1002/hep.24747.
    PubMed     Text format     Related articles    Abstract available



  92. SERSTE T , Barrau V, Ozenne V, Vullierme MP, et al
    Accuracy and disagreement of CT and MRI for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: Role of biopsy.
    Hepatology. 2011 Oct 17. doi: 10.1002/hep.24746.
    PubMed     Text format     Related articles    Abstract available



  93. BERSAGLIERE A , Raduazzo I, Nardi M, Schiff S, et al
    Induced hyperammonaemia may compromise the ability to generate restful sleep in patients with cirrhosis.
    Hepatology. 2011 Oct 12. doi: 10.1002/hep.24741.
    PubMed     Text format     Related articles    Abstract available



  94. LIAO CH , Yeh CT, Huang YH, Wu SM, et al
    Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells.
    Hepatology. 2011 Oct 12. doi: 10.1002/hep.24740.
    PubMed     Text format     Related articles    Abstract available



  95. ROTH CL , Elfers CT, Figlewicz DP, Melhorn SJ, et al
    Vitamin D deficiency in obese rats exacerbates NAFLD and increases hepatic resistin and toll-like receptor activation.
    Hepatology. 2011 Oct 12. doi: 10.1002/hep.24737.
    PubMed     Text format     Related articles    Abstract available



  96. ENAMI Y , Joseph B, Bandi S, Lin J, et al
    Molecular perturbations restrict potential for liver repopulation of hepatocytes isolated from nonheart-beating donor rats.
    Hepatology. 2011 Oct 12. doi: 10.1002/hep.24735.
    PubMed     Text format     Related articles    Abstract available



  97. JOKA D , Wahl K, Moeller S, Schlue J, et al
    Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis.
    Hepatology. 2011 Oct 12. doi: 10.1002/hep.24734.
    PubMed     Text format     Related articles    Abstract available



  98. JOURDAN T , Demizieux L, Gresti J, Djaouti L, et al
    Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver lipid metabolism in mice: Evidence from cultured explants.
    Hepatology. 2011 Oct 10. doi: 10.1002/hep.24733.
    PubMed     Text format     Related articles    Abstract available



  99. MOLLOY JW , Calcagno CJ, Williams CD, Jones FJ, et al
    Association of coffee and caffeine consumption with fatty liver disease, non-alcoholic steatohepatitis, and degree of hepatic fibrosis.
    Hepatology. 2011 Oct 10. doi: 10.1002/hep.24731.
    PubMed     Text format     Related articles    Abstract available



  100. COLLE I
    Targeting angiogenesis in chronic liver diseases with portal hypertension: Anti-PlGF inhibitor or multikinase inhibitor sorafenib?
    Hepatology. 2011 Oct 10. doi: 10.1002/hep.24729.
    PubMed     Text format     Related articles   



  101. ALKHOURI N , Kistangari G, Campbell C, Lopez R, et al
    Mean platelet volume as a marker of increased cardiovascular risk in patients with nonalcoholic steatohepatitis.
    Hepatology. 2011 Oct 3. doi: 10.1002/hep.24721.
    PubMed     Text format     Related articles   



  102. RINELLA ME
    Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?
    Hepatology. 2011;54:1118-20.
    PubMed     Text format     Related articles   



  103. MATO JM , Lu SC
    Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers?
    Hepatology. 2011;54:1115-7.
    PubMed     Text format     Related articles   



  104. WANG Z , Li Z, Ji Y
    Postoperative transcatheter arterial chemoembolization should be recommended in the hepatocellular carcinoma treatment guidelines of the American Association for the Study of Liver Diseases.
    Hepatology. 2011;54:1489-90.
    PubMed     Text format     Related articles   




  105. Abstracts of the American Association for the Study of Liver Diseases 62nd Annual Meeting. November 4-8, 2011. San Francisco, California, USA.
    Hepatology. 2011;54 Suppl:360A-1513A.
    PubMed     Text format     Related articles   



  106. TANAKA S , Mogushi K, Yasen M, Ban D, et al
    Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: A prospective, multicenter study.
    Hepatology. 2011;54:1273-81.
    PubMed     Text format     Related articles    Abstract available



  107. BAGHDASARYAN A , Claudel T, Gumhold J, Silbert D, et al
    Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2(-/-) (Abcb4(-/-) ) mouse cholangiopathy model by promoting biliary HCO 3- output.
    Hepatology. 2011;54:1303-12.
    PubMed     Text format     Related articles    Abstract available



  108. BAUMGARTNER F , Villunger A
    Apoptosis: a barrier against cancer no more?
    Hepatology. 2011;54:1121-4.
    PubMed     Text format     Related articles   



  109. DEVARBHAVI H , Karanth D, Prasanna KS, Adarsh CK, et al
    Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents.
    Hepatology. 2011;54:1344-50.
    PubMed     Text format     Related articles    Abstract available



  110. LOUVET A , Teixeira-Clerc F, Chobert MN, Deveaux V, et al
    Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice.
    Hepatology. 2011;54:1217-26.
    PubMed     Text format     Related articles    Abstract available



  111. GUHA IN , Myers RP, Patel K, Talwalkar JA, et al
    Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve?
    Hepatology. 2011;54:1454-62.
    PubMed     Text format     Related articles    Abstract available



  112. EBRAHIMKHANI MR , Mohar I, Crispe IN
    Cross-presentation of antigen by diverse subsets of murine liver cells.
    Hepatology. 2011;54:1379-87.
    PubMed     Text format     Related articles    Abstract available



  113. VAN SWERINGEN HL , Sakai N, Tevar AD, Burns JM, et al
    CXC chemokine signaling in the liver: impact on repair and regeneration.
    Hepatology. 2011;54:1445-53.
    PubMed     Text format     Related articles    Abstract available



  114. MASCITELLI L , Goldstein MR
    Metabolic syndrome and liver cancer: is excess iron the link?
    Hepatology. 2011;54:1487.
    PubMed     Text format     Related articles   



    September 2011
  115. CHEN Y , Wong PP, Sjeklocha L, Steer CJ, et al
    Mature Hepatocytes Exhibit Unexpected Plasticity by Direct Dedifferentiation into Liver Progenitor Cells in Culture.
    Hepatology. 2011 Sep 27. doi: 10.1002/hep.24712.
    PubMed     Text format     Related articles    Abstract available



  116. ALTEKRUSE SF , McGlynn KA, Dickie LA, Kleiner DE, et al
    Hepatocellular carcinoma confirmation, treatment, and survival in SEER registries, 1992-2008.
    Hepatology. 2011 Sep 27. doi: 10.1002/hep.24710.
    PubMed     Text format     Related articles    Abstract available



  117. CHAN TH , Chen L, Liu M, Hu L, et al
    Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development.
    Hepatology. 2011 Sep 27. doi: 10.1002/hep.24709.
    PubMed     Text format     Related articles    Abstract available



  118. HU M , Wang F, Li X, Rogers CQ, et al
    Regulation of hepatic lipin-1 by ethanol: Role of AMPK-SREBP-1 signaling.
    Hepatology. 2011 Sep 27. doi: 10.1002/hep.24708.
    PubMed     Text format     Related articles    Abstract available



  119. SCHULZE A , Mills K, Weiss TS, Urban S, et al
    Hepatocyte polarization is essential for the productive entry of the hepatitis B virus.
    Hepatology. 2011 Sep 27. doi: 10.1002/hep.24707.
    PubMed     Text format     Related articles    Abstract available



  120. UMEMURA T , Joshita S, Ichijo T, Yoshizawa K, et al
    HLA class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis.
    Hepatology. 2011 Sep 27. doi: 10.1002/hep.24705.
    PubMed     Text format     Related articles    Abstract available



  121. FELIPO V , Ordono JF, Urios A, Mlili NE, et al
    Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests.
    Hepatology. 2011 Sep 27. doi: 10.1002/hep.24704.
    PubMed     Text format     Related articles    Abstract available



  122. SHANG S , Plymoth A, Ge S, Feng Z, et al
    Identification of osteopontin as a novel marker for early hepatocellular carcinoma.
    Hepatology. 2011 Sep 27. doi: 10.1002/hep.24703.
    PubMed     Text format     Related articles    Abstract available



  123. FUEST M , Willim K, Macnelly S, Fellner N, et al
    The transcription factor c-Jun protects against sustained hepatic endoplasmic reticulum stress thereby promoting hepatocyte survival.
    Hepatology. 2011 Sep 27. doi: 10.1002/hep.24699.
    PubMed     Text format     Related articles    Abstract available



  124. NI HM , Bockus A, Boggess N, Jaeschke H, et al
    Activation of autophagy protects against acetaminophen-induced hepatotoxicity.
    Hepatology. 2011 Sep 19. doi: 10.1002/hep.24690.
    PubMed     Text format     Related articles    Abstract available



  125. SHENG L , Shui Y
    CD24 polymorphism and hepatocellular carcinoma.
    Hepatology. 2011 Sep 19. doi: 10.1002/hep.24676.
    PubMed     Text format     Related articles   



  126. WANG C , Yang W, Yan HX, Luo T, et al
    HBx induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) Treated HBx transgenic mice.
    Hepatology. 2011 Sep 19. doi: 10.1002/hep.24675.
    PubMed     Text format     Related articles    Abstract available



  127. GOSHIMA S , Kanematsu M, Kobayashi T, Furukawa T, et al
    Staging hepatic fibrosis: Computer-aided analysis of hepatic contours on Gd-EOB-DTPA-enhanced hepatocyte-phase MR Images.
    Hepatology. 2011 Sep 19. doi: 10.1002/hep.24677.
    PubMed     Text format     Related articles   



  128. BOREL F , Han R, Visser A, Petry H, et al
    ATP-Binding Cassette Transporter Genes Up-Regulation in Untreated Hepatocellular Carcinoma is Mediated by Cellular microRNAs.
    Hepatology. 2011 Sep 19. doi: 10.1002/hep.24682.
    PubMed     Text format     Related articles    Abstract available



  129. STUDER E , Zhou X, Zhao R, Wang Y, et al
    Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes.
    Hepatology. 2011 Sep 19. doi: 10.1002/hep.24681.
    PubMed     Text format     Related articles    Abstract available



  130. BRUIX J , Reig M, Rimola J, Forner A, et al
    Clinical decision making and research in hepatocellular carcinoma. Pivotal role of imaging techniques.
    Hepatology. 2011 Sep 19. doi: 10.1002/hep.24670.
    PubMed     Text format     Related articles   



  131. CORIAT R , Mir O, Goldwasser F, Pol S, et al
    Targeting angiogenesis in chronic liver diseases with portal hypertension: anti-PlGF inhibitor or multikinase inhibitor sorafenib?
    Hepatology. 2011 Sep 19. doi: 10.1002/hep.24688.
    PubMed     Text format     Related articles   



  132. DOI H , Iyer TK, Carpenter E, Li H, et al
    Dysfunctional B-cell activation in cirrhosis due to hepatitis C infection associated with disappearance of CD27+ B-cell population.
    Hepatology. 2011 Sep 19. doi: 10.1002/hep.24689.
    PubMed     Text format     Related articles    Abstract available



  133. LEISE MD , Kim WR, Canterbury KM, Poterucha JJ, et al
    Diagnostic and therapeutic advances in hepatology.
    Hepatology. 2011 Sep 2. doi: 10.1002/hep.24660.
    PubMed     Text format     Related articles   



  134. HUANG HP , Chang MH, Chen YT, Hsu HY, et al
    Persistent elevation of hepatocyte growth factor activator inhibitors in cholangiopathies affects liver fibrosis and differentiation.
    Hepatology. 2011 Sep 2. doi: 10.1002/hep.24657.
    PubMed     Text format     Related articles    Abstract available



  135. MORRIS SM , Baek JY, Koszarek A, Kanngurn S, et al
    TGF-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
    Hepatology. 2011 Sep 2. doi: 10.1002/hep.24653.
    PubMed     Text format     Related articles    Abstract available



  136. AVELLA DM , Li G, Schell TD, Liu D, et al
    Regression of established hepatocellular carcinoma is induced by chemo-immunotherapy in an orthotopic murine model.
    Hepatology. 2011 Sep 2. doi: 10.1002/hep.24652.
    PubMed     Text format     Related articles    Abstract available



  137. ZENG X , Lin Y, Yin C, Zhang X, et al
    Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice.
    Hepatology. 2011 Sep 2. doi: 10.1002/hep.24647.
    PubMed     Text format     Related articles    Abstract available



  138. WU C , Gilroy R, Taylor R, Olyaee M, et al
    Alteration of hepatic nuclear receptor-mediated signaling pathways in HCV patients with and without a history of alcohol drinking.
    Hepatology. 2011 Sep 2. doi: 10.1002/hep.24645.
    PubMed     Text format     Related articles    Abstract available



  139. IAVARONE M , Cabibbo G, Piscaglia F, Zavaglia C, et al
    Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy.
    Hepatology. 2011 Sep 2. doi: 10.1002/hep.24644.
    PubMed     Text format     Related articles    Abstract available



  140. TARRATS N , Moles A, Morales A, Garcia-Ruiz C, et al
    Reply to correspondence: "Hepatic stellate cell proliferation: A potential role of PKR"
    Hepatology. 2011 Sep 2. doi: 10.1002/hep.24640.
    PubMed     Text format     Related articles   



  141. KURIYAMA N , Duarte S, Hamada T, Busuttil RW, et al
    Tenascin-c: A novel mediator of hepatic ischemia and reperfusion injury.
    Hepatology. 2011 Sep 2. doi: 10.1002/hep.24639.
    PubMed     Text format     Related articles    Abstract available



  142. KHALILI K , Kyoung Kim T, Jang HJ, Kochak Yazdi L, et al
    Indeterminate 1-2-cm nodules found on hepatocellular carcinoma surveillance: Biopsy for all, some, or none?
    Hepatology. 2011 Sep 2. doi: 10.1002/hep.24638.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  143. VANDERPOOL C , Sparks EE, Huppert KA, Gannon M, et al
    Genetic interactions between hepatocyte nuclear factor-6 and notch signaling regulate mouse intrahepatic bile duct development in vivo.
    Hepatology. 2011 Aug 24. doi: 10.1002/hep.24631.
    PubMed     Text format     Related articles    Abstract available



  144. LLEO A , Liao J, Invernizzi P, Zhao M, et al
    IgM levels inversely correlate with cd40l promoter methylation in patients with primary biliary cirrhosis Hepatology-Ana lleo library 4-26.
    Hepatology. 2011 Aug 24. doi: 10.1002/hep.24630.
    PubMed     Text format     Related articles    Abstract available



  145. NODA T , Shimoda M, Ortiz V, Sirica AE, et al
    Immunization with ASPH-loaded dendritic cells produces anti-tumor effects in a rat model of intrahepatic cholangiocarcinoma.
    Hepatology. 2011 Aug 24. doi: 10.1002/hep.24629.
    PubMed     Text format     Related articles    Abstract available



  146. SUNG PS , Yoon SK
    Amiodarone-induced liver cirrhosis.
    Hepatology. 2011 Aug 24. doi: 10.1002/hep.24627.
    PubMed     Text format     Related articles   



  147. DENG Y , Foley EM, Gonzales JC, Gordts PL, et al
    Shedding of syndecan-1 from human hepatocytes alters VLDL clearance.
    Hepatology. 2011 Aug 24. doi: 10.1002/hep.24626.
    PubMed     Text format     Related articles    Abstract available



  148. OLSON JC , Wendon JA, Kramer DJ, Arroyo V, et al
    Intensive care of the patient with cirrhosis.
    Hepatology. 2011 Aug 24. doi: 10.1002/hep.24622.
    PubMed     Text format     Related articles    Abstract available



  149. KIM SJ , Kim YC
    Unusual extrahepatic metastasis to the soft tissue of the left cervical neck area from hepatic epithelioid hemangioendothelioma (EHE).
    Hepatology. 2011 Aug 19. doi: 10.1002/hep.24617.
    PubMed     Text format     Related articles   



  150. RAKOSKI MO , McCammon RJ, Piette JD, Iwashyna TJ, et al
    Burden of cirrhosis on older americans and their families: Analysis of the health and retirement study.
    Hepatology. 2011 Aug 19. doi: 10.1002/hep.24616.
    PubMed     Text format     Related articles    Abstract available



  151. CANO A , Buque X, Martinez-Una M, Aurrekoetxea I, et al
    Methionine adenosyltransferase 1A gene deletion disrupts hepatic VLDL assembly in mice.
    Hepatology. 2011 Aug 11. doi: 10.1002/hep.24607.
    PubMed     Text format     Related articles    Abstract available



  152. YUAN JH , Yang F, Chen BF, Lu Z, et al
    The histone deacetylase 4/Sp1/miR-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma.
    Hepatology. 2011 Aug 11. doi: 10.1002/hep.24606.
    PubMed     Text format     Related articles    Abstract available



  153. MANDREKAR P , Ambade A, Lim A, Szabo G, et al
    An essential role for MCP-1 in alcoholic liver injury: Regulation of pro-inflammatory cytokines and hepatic steatosis.
    Hepatology. 2011 Aug 8. doi: 10.1002/hep.24599.
    PubMed     Text format     Related articles    Abstract available



  154. MCNALLY RJ , James PW, Ducker S, James OF, et al
    Seasonal variation in the diagnosis of primary biliary cirrhosis: Further evidence for an environmental component to etiology.
    Hepatology. 2011 Aug 8. doi: 10.1002/hep.24597.
    PubMed     Text format     Related articles    Abstract available



  155. ZHANG JF , He ML, Fu WM, Wang H, et al
    Primate-specific miRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting stat3 signaling.
    Hepatology. 2011 Aug 1. doi: 10.1002/hep.24595.
    PubMed     Text format     Related articles    Abstract available



  156. CARDINALE V , Wang Y, Carpino G, Cui CB, et al
    Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes and pancreatic islets.
    Hepatology. 2011 Aug 1. doi: 10.1002/hep.24590.
    PubMed     Text format     Related articles    Abstract available



  157. LORENZON L , Ziparo V
    Von Meyenburg complexes mimicking liver metastases.
    Hepatology. 2011;54:734-5.
    PubMed     Text format     Related articles   



  158. THABUT D , Routray C, Lomberk G, Shergill U, et al
    Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis.
    Hepatology. 2011;54:573-85.
    PubMed     Text format     Related articles    Abstract available



  159. MENCIN A , Gwak GY, Schwabe RF
    Mechanisms by which TLR4 and endotoxin promote hepatocellular carcinoma require further investigation.
    Hepatology. 2011;54:745.
    PubMed     Text format     Related articles   



  160. CINAROGLU A , Gao C, Imrie D, Sadler KC, et al
    Activating transcription factor 6 plays protective and pathological roles in steatosis due to endoplasmic reticulum stress in zebrafish.
    Hepatology. 2011;54:495-508.
    PubMed     Text format     Related articles    Abstract available



  161. WELZEL TM , Graubard BI, Zeuzem S, El-Serag HB, et al
    Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.
    Hepatology. 2011;54:463-71.
    PubMed     Text format     Related articles    Abstract available



  162. NEUSCHWANDER-TETRI BA
    No transfats.
    Hepatology. 2011;54:750-1.
    PubMed     Text format     Related articles   



  163. BALABAUD C
    Liver biopsy interpretation in liver cancer.
    Hepatology. 2011;54:750.
    PubMed     Text format     Related articles   



  164. CLARIDGE LC
    Detection of acetaminophen-cysteine adducts in cases of indeterminate liver failure is not diagnostic of intentional overdose.
    Hepatology. 2011;54:746-7.
    PubMed     Text format     Related articles   



  165. MIRAGOLI M , Kadir SH, Sheppard MN, Salvarani N, et al
    A protective antiarrhythmic role of ursodeoxycholic acid in an in vitro rat model of the cholestatic fetal heart.
    Hepatology. 2011 Aug 1. doi: 10.1002/hep.24492.
    PubMed     Text format     Related articles    Abstract available



  166. STAUFER K , Andresen H, Vettorazzi E, Tobias N, et al
    Urinary ethyl glucuronide as a novel screening tool in patients pre and post liver transplantation improves detection of alcohol consumption.
    Hepatology. 2011 Aug 1. doi: 10.1002/hep.24596.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  167. URTASUN R , Latasa M, Demartis M, Balzani S, et al
    Connective tissue growth factor autocriny in hepatocellular carcinoma: Oncogenic role and regulation by EGFR/YAP-mediated activation.
    Hepatology. 2011 Jul 28. doi: 10.1002/hep.24587.
    PubMed     Text format     Related articles    Abstract available



  168. VANWIJNGAERDEN YM , Wauters J, Langouche L, Vander Perre S, et al
    Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression.
    Hepatology. 2011 Jul 28. doi: 10.1002/hep.24582.
    PubMed     Text format     Related articles    Abstract available



  169. CECCARELLI S , Panera N, Alisi A, Nobili V, et al
    Hepatic stellate cell proliferation: A potential role of PKR.
    Hepatology. 2011 Jul 28. doi: 10.1002/hep.24579.
    PubMed     Text format     Related articles   



  170. HEIMBACH JK , Wiesner RH
    The benefit of living donor liver transplantation: Who and when?
    Hepatology. 2011 Jul 28. doi: 10.1002/hep.24578.
    PubMed     Text format     Related articles   



  171. GAL-TANAMY M , Bachmetov L, Ravid A, Koren R, et al
    Vitamin-D: An innate antiviral agent suppressing Hepatitis C virus in human hepatocytes.
    Hepatology. 2011 Jul 25. doi: 10.1002/hep.24575.
    PubMed     Text format     Related articles    Abstract available



  172. CAO H , Krueger EW, McNiven MA
    Hepatocytes internalize trophic receptors at large endocytic "hot spots"
    Hepatology. 2011 Jul 25. doi: 10.1002/hep.24572.
    PubMed     Text format     Related articles    Abstract available



  173. LEE HY , Birkenfeld AL, Jornayvaz FR, Jurczak MJ, et al
    Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance.
    Hepatology. 2011 Jul 25. doi: 10.1002/hep.24571.
    PubMed     Text format     Related articles    Abstract available



  174. POON RT
    Prevention of recurrence after resection of hepatocellular carcinoma: A daunting challenge.
    Hepatology. 2011 Jul 25. doi: 10.1002/hep.24569.
    PubMed     Text format     Related articles    Abstract available



  175. SCHILDBERG FA , Kurts C, Knolle PA
    Prominent regulatory but weak antigen-presenting cell function of hepatic stellate cells.
    Hepatology. 2011 Jul 25. doi: 10.1002/hep.24565.
    PubMed     Text format     Related articles   



  176. MORISAWA T , Yoshikawa T, Nabeshima M
    Hepatic tuberculosis in a patient treated with infliximab.
    Hepatology. 2011 Jul 25. doi: 10.1002/hep.24564.
    PubMed     Text format     Related articles   



  177. RAZUMILAVA N , Gores GJ, Lindor KD
    Cancer surveillance in patients with primary sclerosing cholangitis.
    Hepatology. 2011 Jul 25. doi: 10.1002/hep.24570.
    PubMed     Text format     Related articles    Abstract available



  178. YANG F , Zhang L, Huo XS, Yuan JH, et al
    Long non-coding RNA high expressed in hepatocellular carcinoma (lncRNA-HEIH) facilitates tumor growth through enhancer of zeste homolog 2.
    Hepatology. 2011 Jul 18. doi: 10.1002/hep.24563.
    PubMed     Text format     Related articles    Abstract available



  179. MEI Y , Thevananther S
    Endothelial nitric oxide synthase is a key mediator of hepatocyte proliferation in response to partial hepatectomy in mice.
    Hepatology. 2011 Jul 11. doi: 10.1002/hep.24560.
    PubMed     Text format     Related articles    Abstract available



  180. TORRES D , Jones F, Shaw J, Williams C, et al
    Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis (NASH): A 12 month-randomized, prospective, open- label trial.
    Hepatology. 2011 Jul 11. doi: 10.1002/hep.24558.
    PubMed     Text format     Related articles    Abstract available



  181. RINELLA ME , Siddiqui MS, Gardikiotes K, Gottstein J, et al
    Dysregulation of the unfolded protein response in db/db mice with diet induced steatohepatitis.
    Hepatology. 2011 Jul 11. doi: 10.1002/hep.24553.
    PubMed     Text format     Related articles    Abstract available



  182. KRUGLOV EA , Gautam S, Guerra MT, Nathanson MH, et al
    Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes.
    Hepatology. 2011 Jul 11. doi: 10.1002/hep.24548.
    PubMed     Text format     Related articles    Abstract available



  183. GKOUVATSOS K , Wagner J, Papanikolaou G, Sebastiani G, et al
    Conditional disruption of mouse Hfe2 gene: Maintenance of systemic iron homeostasis requires hepatic but not skeletal muscle hemojuvelin.
    Hepatology. 2011 Jul 11. doi: 10.1002/hep.24547.
    PubMed     Text format     Related articles    Abstract available



  184. ZEIN CO , Yerian LM, Gogate P, Lopez R, et al
    Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial.
    Hepatology. 2011 Jul 11. doi: 10.1002/hep.24544.
    PubMed     Text format     Related articles    Abstract available



  185. SUN T , Sun BC, Zhao XL, Zhao N, et al
    Promotion of tumor cell metastasis and vasculogenic mimicry via transcription co-activation by Bcl-2 and Twist1: a study on hepatocellular carcinoma.
    Hepatology. 2011 Jul 11. doi: 10.1002/hep.24543.
    PubMed     Text format     Related articles    Abstract available



  186. WANG X , Wu D, Yang L, Cederbaum AI, et al
    Hepatotoxicity mediated by pyrazole (CYP2E1) Plus TNF-alpha treatment occurs in jnk2(-/-) but not in jnk1(-/-) Mice.
    Hepatology. 2011 Jul 11. doi: 10.1002/hep.24540.
    PubMed     Text format     Related articles    Abstract available



  187. KIM Y , Jang M, Lim S, Won H, et al
    Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma.
    Hepatology. 2011 Jul 11. doi: 10.1002/hep.24539.
    PubMed     Text format     Related articles    Abstract available



  188. LI L , Chen L, Hu L, Liu Y, et al
    Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.
    Hepatology. 2011 Jul 11. doi: 10.1002/hep.24552.
    PubMed     Text format     Related articles    Abstract available



  189. WONG DK , Huang FY, Lai CL, Poon RT, et al
    Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma.
    Hepatology. 2011 Jul 11. doi: 10.1002/hep.24551.
    PubMed     Text format     Related articles    Abstract available



  190. BHAVE VS , Paranjpe S, Bowen WC, Donthamsetty S, et al
    Genes inducing iPS phenotype play a role in hepatocyte survival and proliferation in vitro and liver regeneration in vivo.
    Hepatology. 2011 Jul 7. doi: 10.1002/hep.24507.
    PubMed     Text format     Related articles    Abstract available



  191. SUN W , Ding J, Wu K, Ning BF, et al
    Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of hepatocytes and hepatoma cells.
    Hepatology. 2011 Jul 6. doi: 10.1002/hep.24530.
    PubMed     Text format     Related articles    Abstract available



  192. TSUDA M , Ambrosini YM, Zhang W, Yang GX, et al
    Fine phenotypic and functional characterization of effector CD8(+) T cells in patients with primary biliary cirrhosis.
    Hepatology. 2011 Jul 6. doi: 10.1002/hep.24526.
    PubMed     Text format     Related articles    Abstract available



  193. WANG YD , Chen WD, Yu D, Forman BM, et al
    The G-protein coupled bile acid receptor Gpbar1 (TGR5) negatively regulates hepatic inflammatory response through antagonizing Nuclear Factor kappaB.
    Hepatology. 2011 Jul 6. doi: 10.1002/hep.24525.
    PubMed     Text format     Related articles    Abstract available



  194. MAZUMDAR B , Banerjee A, Meyer K, Ray R, et al
    Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes.
    Hepatology. 2011 Jul 6. doi: 10.1002/hep.24523.
    PubMed     Text format     Related articles    Abstract available



  195. HO CM , Lee PH, Hu RH
    Clinical correlation of miR-375 and alpha-fetoprotein in hepatocellular carcinoma: Comparison in mice and humans.
    Hepatology. 2011 Jul 6. doi: 10.1002/hep.24521.
    PubMed     Text format     Related articles   



  196. SARIN SK , Sharma P
    Terlipressin - an asset for Hepatologists!
    Hepatology. 2011 Jul 6. doi: 10.1002/hep.24519.
    PubMed     Text format     Related articles   



  197. TENG CF , Wu HC, Tsai HW, Shiah HS, et al
    Novel feedback inhibition of surface antigen synthesis by mTOR signal and its implication for hepatitis B virus tumorigenesis and therapy.
    Hepatology. 2011 Jul 6. doi: 10.1002/hep.24529.
    PubMed     Text format     Related articles    Abstract available



  198. QIU W , Wang X, Leibowitz B, Yang W, et al
    PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice.
    Hepatology. 2011 Jul 2. doi: 10.1002/hep.24516.
    PubMed     Text format     Related articles    Abstract available



  199. TAO W , Chen S, Shi G, Guo J, et al
    The SWI/SNF complex subunit BAF60a integrates hepatic circadian clock and energy metabolism.
    Hepatology. 2011 Jul 2. doi: 10.1002/hep.24514.
    PubMed     Text format     Related articles    Abstract available



  200. ALISI A , Romania P, Nobili V, Locatelli F, et al
    Human hepatic stellate cells are liver-resident antigen presenting cells.
    Hepatology. 2011 Jul 2. doi: 10.1002/hep.24511.
    PubMed     Text format     Related articles   



  201. MUELLER KM , Kornfeld JW, Friedbichler K, Blaas L, et al
    Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice.
    Hepatology. 2011 Jul 2. doi: 10.1002/hep.24509.
    PubMed     Text format     Related articles    Abstract available



  202. NAIR SS , Bommana A, Pakala SB, Ohshiro K, et al
    Inflammatory response to liver fluke Opisthorchis viverrini depends on host master coregulator, MTA1, a marker for parasite induced cholangiocarcinoma.
    Hepatology. 2011 Jul 2. doi: 10.1002/hep.24518.
    PubMed     Text format     Related articles    Abstract available



  203. GIANNINI EG , Farinati F, Trevisani F
    Alpha-fetoprotein in hepatocellular carcinoma surveillance: Wake not the dead.
    Hepatology. 2011;54:376-7.
    PubMed     Text format     Related articles   



  204. RAMM GA
    Anti-chemokine therapy for the treatment of hepatic fibrosis: An attractive approach.
    Hepatology. 2011;54:354-8.
    PubMed     Text format     Related articles   



  205. SHEN L
    Treatment implication from the potential association between nonalcoholic fatty liver disease and cardiovascular disease.
    Hepatology. 2011;54:377-8.
    PubMed     Text format     Related articles   



  206. BRUIX J
    Liver cancer: still a long way to go.
    Hepatology. 2011;54:1-2.
    PubMed     Text format     Related articles   



  207. ADAMS LA
    Mortality in nonalcoholic fatty liver disease: clues from the Cremona study.
    Hepatology. 2011;54:6-8.
    PubMed     Text format     Related articles   



  208. CALVISI DF
    Dr. Jekyll and Mr. Hyde: a paradoxical oncogenic and tumor suppressive role of signal transducer and activator of transcription 3 in liver cancer.
    Hepatology. 2011;54:9-12.
    PubMed     Text format     Related articles   



  209. PARSONS MJ , Green DR
    Death receptors and mitochondria: life depends on the liver.
    Hepatology. 2011;54:13-5.
    PubMed     Text format     Related articles   



  210. GALBOIS A , Thabut D, Moreau R, Lebrec D, et al
    Neutralization of lipopolysaccharide effects in liver diseases, the quest for the Holy Grail.
    Hepatology. 2011;54:376.
    PubMed     Text format     Related articles   



  211. JI C , Kaplowitz N, Lau MY, Kao E, et al
    Liver-specific loss of glucose-regulated protein 78 perturbs the unfolded protein response and exacerbates a spectrum of liver diseases in mice.
    Hepatology. 2011;54:229-39.
    PubMed     Text format     Related articles    Abstract available



  212. CALORI G , Lattuada G, Ragogna F, Garancini MP, et al
    Fatty liver index and mortality: the Cremona study in the 15th year of follow-up.
    Hepatology. 2011;54:145-52.
    PubMed     Text format     Related articles    Abstract available



  213. NAIR SS , Bommana A, Bethony JM, Lyon AJ, et al
    The metastasis-associated protein-1 gene encodes a host permissive factor for schistosomiasis, a leading global cause of inflammation and cancer.
    Hepatology. 2011;54:285-95.
    PubMed     Text format     Related articles    Abstract available



  214. BRUNT EM , Kleiner DE, Behling C, Contos MJ, et al
    Misuse of scoring systems.
    Hepatology. 2011;54:369-70.
    PubMed     Text format     Related articles   



  215. DUCLOS-VALLEE JC , Ichai P, Samuel D
    Autoimmune acute liver failure.
    Hepatology. 2011;54:372-3.
    PubMed     Text format     Related articles   



    June 2011
  216. THOMPSON MD , Wickline ED, Bowen WB, Lu A, et al
    Spontaneous repopulation of beta-catenin null livers with beta-catenin positive hepatocytes after chronic murine liver injury.
    Hepatology. 2011 Jun 30. doi: 10.1002/hep.24506.
    PubMed     Text format     Related articles    Abstract available



  217. KOGURE T , Lin WL, Yan IK, Braconi C, et al
    Inter-cellular nanovesicle mediated microRNA transfer: A mechanism of environmental modulation of hepatocellular cancer cell growth.
    Hepatology. 2011 Jun 30. doi: 10.1002/hep.24504.
    PubMed     Text format     Related articles    Abstract available



  218. KAMATH PS
    Publications in Hepatology: Is there a pro- United States bias?
    Hepatology. 2011 Jun 17. doi: 10.1002/hep.24497.
    PubMed     Text format     Related articles   



  219. JIA D , Wei L, Guo W, Zha R, et al
    Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma.
    Hepatology. 2011 Jun 17. doi: 10.1002/hep.24495.
    PubMed     Text format     Related articles    Abstract available



  220. AHMED MM , Wang T, Luo Y, Ye S, et al
    Aldo-keto reductase-7A protects liver cells and tissues from acetaminophen-induced oxidative stress and hepatotoxicity.
    Hepatology. 2011 Jun 17. doi: 10.1002/hep.24493.
    PubMed     Text format     Related articles    Abstract available



  221. BHALA N , Angulo P, van der Poorten D, Lee E, et al
    The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study.
    Hepatology. 2011 Jun 17. doi: 10.1002/hep.24491.
    PubMed     Text format     Related articles    Abstract available



  222. BERG CL , Merion RM, Shearon TH, Olthoff KM, et al
    Liver transplant recipient survival benefit with living donation in the MELD allocation era.
    Hepatology. 2011 Jun 17. doi: 10.1002/hep.24494.
    PubMed     Text format     Related articles    Abstract available



  223. SHAO B , Kitchens R, Munford R, Rogers TE, et al
    Prolonged hepatomegaly in mice that cannot inactivate bacterial endotoxin.
    Hepatology. 2011 Jun 14. doi: 10.1002/hep.24488.
    PubMed     Text format     Related articles    Abstract available



  224. JIANG R , Tan Z, Deng L, Chen Y, et al
    IL-22 promotes human hepatocellular carcinoma by activation of STAT3.
    Hepatology. 2011 Jun 14. doi: 10.1002/hep.24486.
    PubMed     Text format     Related articles    Abstract available



  225. LOMONACO R , Ortiz-Lopez C, Orsak B, Finch J, et al
    Role of ethnicity in overweight and obese subjects with nonalcoholic steatohepatitis (NASH).
    Hepatology. 2011 Jun 14. doi: 10.1002/hep.24483.
    PubMed     Text format     Related articles    Abstract available



  226. LI H , Ge C, Zhao F, Yan M, et al
    HIF-1alpha-activated ANGPTL4 contributes to tumor metastasis via VCAM-1/integrin beta1 signaling in human hepatocellular carcinoma.
    Hepatology. 2011 Jun 14. doi: 10.1002/hep.24479.
    PubMed     Text format     Related articles    Abstract available



  227. GUY CS , Rankin SL, Michalak TI
    Hepatocyte cytotoxicity is facilitated by asialoglycoprotein receptor.
    Hepatology. 2011 Jun 7. doi: 10.1002/hep.24477.
    PubMed     Text format     Related articles    Abstract available



  228. LOTERSZTAJN S , Teixeira-Clerc F, Deveaux V, Manin S, et al
    Association of the cannabinoid receptor 2 (CB2) Q63R variant with indices of liver damage in obese children: An alternative way to highlight the CB2 hepatoprotective properties: Reply.
    Hepatology. 2011 Jun 7. doi: 10.1002/hep.24476.
    PubMed     Text format     Related articles   



  229. YU HC , Qin HY, He F, Wang L, et al
    Canonical Notch pathway protects hepatocytes from ischemia reperfusion injury by repressing ROS production through JAK2/STAT3 signaling.
    Hepatology. 2011 Jun 1. doi: 10.1002/hep.24469.
    PubMed     Text format     Related articles    Abstract available



  230. BALLESTRI S , Lonardo A, Loria P
    Nonalcoholic fatty liver disease activity score and Brunt's pathologic criteria for the diagnosis of nonalcoholic steatohepatitis: What do they mean and do they agree?
    Hepatology. 2011;53:2142-3.
    PubMed     Text format     Related articles   



  231. HUPPERT SS
    A new set of classifications for ductal plate malformations.
    Hepatology. 2011;53:1795-7.
    PubMed     Text format     Related articles   



  232. CORDERO P , Campion J, Milagro FI, Martinez JA, et al
    Dietary supplementation with methyl donor groups could prevent nonalcoholic fatty liver.
    Hepatology. 2011;53:2151-2.
    PubMed     Text format     Related articles   



  233. WHITE JS , Foreyt JP
    Two solutions in search of a problem.
    Hepatology. 2011;53:2148.
    PubMed     Text format     Related articles   



  234. LIU L , Shao JH, Wang K, Hua FZ, et al
    Methodological concerns about a recent meta-analysis of the influence of the I148M variant of patatin-like phospholipase domain containing 3 on the susceptibility and histological severity of nonalcoholic fatty liver disease.
    Hepatology. 2011;53:2145.
    PubMed     Text format     Related articles   



  235. THOMAS JA , Pope C, Wojtacha D, Robson AJ, et al
    Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function.
    Hepatology. 2011;53:2003-15.
    PubMed     Text format     Related articles    Abstract available



  236. BREUHAHN K , Gores G, Schirmacher P
    Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches.
    Hepatology. 2011;53:2112-21.
    PubMed     Text format     Related articles    Abstract available



  237. ROSSELLI MS , Burgueno AL, Pirola CJ, Sookoian S, et al
    Cyclooxygenase inhibition up-regulates liver carnitine palmitoyltransferase 1A expression and improves fatty liver.
    Hepatology. 2011;53:2143-4.
    PubMed     Text format     Related articles   



  238. SHEN L
    More on vitamin C deficiency in mice and humans.
    Hepatology. 2011;53:2139.
    PubMed     Text format     Related articles   



  239. LI J , Chi Y, Wang C, Wu J, et al
    Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway.
    Hepatology. 2011;53:1906-16.
    PubMed     Text format     Related articles    Abstract available



  240. ANTHERIEU S , Rogue A, Fromenty B, Guillouzo A, et al
    Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells.
    Hepatology. 2011;53:1895-905.
    PubMed     Text format     Related articles    Abstract available



  241. KOWALIK MA , Saliba C, Pibiri M, Perra A, et al
    Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice.
    Hepatology. 2011;53:2086-96.
    PubMed     Text format     Related articles    Abstract available



  242. SOOKOIAN S , Pirola CJ
    Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.
    Hepatology. 2011;53:1883-94.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  243. RAMIREZ R , Cohen JC, Hobbs HH, Browning JD, et al
    Hepatic triglyceride content in individuals with reduced intestinal cholesterol absorption due to variants in NPC1L1.
    Hepatology. 2011 May 29. doi: 10.1002/hep.24461.
    PubMed     Text format     Related articles   



  244. LI F , Song Z, Li Q, Wu J, et al
    Molecular imaging of hepatic stellate cell activity by visualization of hepatic integrin alphavbeta3 expression with SPECT in rat.
    Hepatology. 2011 May 26. doi: 10.1002/hep.24467.
    PubMed     Text format     Related articles    Abstract available



  245. MARQUARDT JU , Raggi C, Andersen JB, Seo D, et al
    Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways.
    Hepatology. 2011 May 26. doi: 10.1002/hep.24454.
    PubMed     Text format     Related articles    Abstract available



  246. SANGRO B , Carpanese L, Cianni R, Golfieri R, et al
    Survival after (90) Y resin microsphere radioembolization of hepatocellular carcinoma across BCLC stages: A European evaluation.
    Hepatology. 2011 May 26. doi: 10.1002/hep.24451.
    PubMed     Text format     Related articles    Abstract available



  247. YOU H , Ding W, Dang H, Jiang Y, et al
    c-Met represents a potential therapeutic target for personalized treatment in Hepatocellular carcinoma.
    Hepatology. 2011 May 26. doi: 10.1002/hep.24450.
    PubMed     Text format     Related articles    Abstract available



  248. CHUA AC , Trinder D, Olynyk JK
    Liver and serum iron - discrete regulators of hepatic hepcidin expression.
    Hepatology. 2011 May 26. doi: 10.1002/hep.24449.
    PubMed     Text format     Related articles   



  249. MCMAHON BJ , Bulkow LR, Singleton RJ, Williams J, et al
    Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program.
    Hepatology. 2011 May 26. doi: 10.1002/hep.24442.
    PubMed     Text format     Related articles    Abstract available



  250. ROSSI F , Bellini G, Nobili B, Maione S, et al
    Association of the cannabinoid receptor 2 (CB2) Q63R polymorphism with indices of liver damage in obese children: An alternative way to highlight the CB2 hepatoprotective properties.
    Hepatology. 2011 May 23. doi: 10.1002/hep.24440.
    PubMed     Text format     Related articles   



  251. KALAMBOKIS GN , Tsianos EV
    Raised sympathetic activity and blood ammonia could increase sensitivity to infections in patients with cirrhosis and refractory ascites on beta-blockers.
    Hepatology. 2011 May 23. doi: 10.1002/hep.24439.
    PubMed     Text format     Related articles   



  252. AMIN A , Hamza AA, Bajbouj K, Ashraf SS, et al
    Saffron: A potential target for a novel anti-cancer drug against hepatocellular carcinoma.
    Hepatology. 2011 May 23. doi: 10.1002/hep.24433.
    PubMed     Text format     Related articles    Abstract available



  253. LIU T , Wang Y, Wen C, Zhang S, et al
    Stem cells or macrophages, which contribute to bone marrow cell therapy for liver cirrhosis?
    Hepatology. 2011 May 23. doi: 10.1002/hep.24431.
    PubMed     Text format     Related articles   



  254. YOSHIDA H , Shiratori Y, Kudo M, Shiina S, et al
    Effect of vitamin K2 on the recurrence of hepatocellular carcinoma: A randomized, placebo-controlled, double-blind phase II/III study.
    Hepatology. 2011 May 13. doi: 10.1002/hep.24430.
    PubMed     Text format     Related articles    Abstract available



  255. CONNOLLY MK , Ayo D, Malhotra A, Hackman M, et al
    Dendritic cell depletion exacerbates acetaminophen hepatotoxicity.
    Hepatology. 2011 May 13. doi: 10.1002/hep.24429.
    PubMed     Text format     Related articles    Abstract available



  256. CHEN Y , Yang F, Lu H, Wang B, et al
    Characterization of fecal microbial communities in patients with liver cirrhosis.
    Hepatology. 2011 May 13. doi: 10.1002/hep.24423.
    PubMed     Text format     Related articles    Abstract available



  257. JNL S , Jc GP, Dc V, Hla J, et al
    Idiopathic non-cirrhotic portal hypertension.
    Hepatology. 2011 May 13. doi: 10.1002/hep.24422.
    PubMed     Text format     Related articles    Abstract available



  258. LIN CW , Mars WM, Paranjpe S, Donthamsetty S, et al
    Hepatocyte proliferation and hepatomegaly induced by phenobarbital and TCPOBOP is suppressed in hepatocyte-targeted glypica 3 transgenic mice.
    Hepatology. 2011 May 13. doi: 10.1002/hep.24417.
    PubMed     Text format     Related articles    Abstract available



  259. ZHANG J , Handy DE, Wang Y, Bouchard G, et al
    Hyperhomocysteinemia from trimethylation of hepatic phosphatidylethanolamine during cholesterol cholelithogenesis in inbred mice.
    Hepatology. 2011 May 12. doi: 10.1002/hep.24428.
    PubMed     Text format     Related articles    Abstract available



  260. KALAMBOKIS GN , Mouzaki A, Rodi M, Pappas K, et al
    Bacterial translocation attenuates the systemic hemodynamic improvement produced by terlipressin in patients with cirrhosis.
    Hepatology. 2011 May 12. doi: 10.1002/hep.24424.
    PubMed     Text format     Related articles   



  261. BERZIGOTTI A , Garcia-Tsao G, Bosch J, Grace N, et al
    Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis.
    Hepatology. 2011 May 12. doi: 10.1002/hep.24418.
    PubMed     Text format     Related articles    Abstract available



  262. INVERNIZZI P
    HLA in primary biliary cirrhosis: An old story now reviving.
    Hepatology. 2011 May 11. doi: 10.1002/hep.24414.
    PubMed     Text format     Related articles    Abstract available



  263. TAROCCHI M , Hannivoort R, Hoshida Y, Lee UE, et al
    Carcinogen-induced hepatic tumors in KLF6+/- mice recapitulate aggressive human hepatocellular carcinoma, associated with p53 pathway deregulation.
    Hepatology. 2011 May 11. doi: 10.1002/hep.24413.
    PubMed     Text format     Related articles    Abstract available



  264. ANGULO P
    Diagnosing steatohepatitis and predicting liver-related mortality in nafld: Two distinct concepts.
    Hepatology. 2011 May 6. doi: 10.1002/hep.24403.
    PubMed     Text format     Related articles   



  265. NGUYEN D , Talwalkar JA
    Diagnostic and therapeutic advances in Hepatology noninvasive assessment of liver fibrosis.
    Hepatology. 2011 May 5. doi: 10.1002/hep.24401.
    PubMed     Text format     Related articles   



  266. WANG Y , Guo Y, Wang F, Sun S, et al
    Pathogen DNA also contributes to interferon regulatory factor 3 activation in hepatic cells: Implications for alcoholic liver diseases.
    Hepatology. 2011;53:1783-4.
    PubMed     Text format     Related articles   



  267. AGUSTIN A , Javier Z
    Beta-blockers in patients with cirrhosis and refractory ascites.
    Hepatology. 2011;53:1783.
    PubMed     Text format     Related articles   



  268. DI BENEDETTO F , Tarantino G, Montalti R, D'Amico G, et al
    The impact of human immunodeficiency virus infection in liver transplantation for hepatocellular carcinoma.
    Hepatology. 2011;53:1777-8.
    PubMed     Text format     Related articles   



  269. SWEETSER S , Loftus CG
    Massive hepatic echinococcosis.
    Hepatology. 2011;53:1771-2.
    PubMed     Text format     Related articles   



  270. MATRAI J , Cantore A, Bartholomae CC, Annoni A, et al
    Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk.
    Hepatology. 2011;53:1696-707.
    PubMed     Text format     Related articles   



  271. CHU AS , Diaz R, Hui JJ, Yanger K, et al
    Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis.
    Hepatology. 2011;53:1685-95.
    PubMed     Text format     Related articles   



  272. BAEK HJ , Pishvaian MJ, Tang Y, Kim TH, et al
    Transforming growth factor-beta adaptor, beta2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancer.
    Hepatology. 2011;53:1676-84.
    PubMed     Text format     Related articles   



  273. STEENKISTE CV , Ribera J, Geerts A, Pauta M, et al
    Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice.
    Hepatology. 2011;53:1629-40.
    PubMed     Text format     Related articles   



  274. STUART WD , Kulkarni RM, Gray JK, Vasiliauskas J, et al
    Ron receptor regulates Kupffer cell-dependent cytokine production and hepatocyte survival following endotoxin exposure in mice.
    Hepatology. 2011;53:1618-28.
    PubMed     Text format     Related articles   



  275. HARTMANN D , Srivastava U, Thaler M, Kleinhans KN, et al
    Telomerase gene mutations are associated with cirrhosis formation.
    Hepatology. 2011;53:1608-17.
    PubMed     Text format     Related articles   



  276. CALADO RT , Brudno J, Mehta P, Kovacs JJ, et al
    Constitutional telomerase mutations are genetic risk factors for cirrhosis.
    Hepatology. 2011;53:1600-7.
    PubMed     Text format     Related articles   



  277. BHANGUI P , Vibert E, Majno P, Salloum C, et al
    Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: Living versus deceased donor transplantation.
    Hepatology. 2011;53:1570-9.
    PubMed     Text format     Related articles   



  278. SZE KM , Wong KL, Chu GK, Lee JM, et al
    Loss of phosphatase and tensin homolog enhances cell invasion and migration through aKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance.
    Hepatology. 2011;53:1558-69.
    PubMed     Text format     Related articles   



  279. DI TOMMASO L , Destro A, Fabbris V, Spagnuolo G, et al
    Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma.
    Hepatology. 2011;53:1549-57.
    PubMed     Text format     Related articles   



  280. YOO BK , Santhekadur PK, Gredler R, Chen D, et al
    Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma.
    Hepatology. 2011;53:1538-48.
    PubMed     Text format     Related articles   



  281. NATH B , Levin I, Csak T, Petrasek J, et al
    Hepatocyte-specific hypoxia-inducible factor-1alpha is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice.
    Hepatology. 2011;53:1526-37.
    PubMed     Text format     Related articles   



  282. ZHANG X , Zhang E, Ma Z, Pei R, et al
    Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1.
    Hepatology. 2011;53:1476-85.
    PubMed     Text format     Related articles   



  283. SALAMONE F , Galvano F, Li Volti G
    Insulin resistance links nonalcoholic fatty liver to cardiovascular diseases.
    Hepatology. 2011;53:1785-6.
    PubMed     Text format     Related articles   



  284. FUJITA T
    Is endotoxemia a therapeutic target in liver injury?
    Hepatology. 2011;53:1785.
    PubMed     Text format     Related articles   



  285. MUSSO G , Gambino R, Cassader M
    Need for a three-focused approach to nonalcoholic fatty liver disease.
    Hepatology. 2011;53:1773.
    PubMed     Text format     Related articles   



  286. SHARMA AD , Narain N, Handel EM, Iken M, et al
    MicroRNA-221 regulates FAS-induced fulminant liver failure.
    Hepatology. 2011;53:1651-61.
    PubMed     Text format     Related articles    Abstract available



  287. DEGOS F , Lebrun L, Perez P, Durand-Zaleski I, et al
    Methods and interest of noninvasive assessment of liver fibrosis are still in debate.
    Hepatology. 2011;53:1781.
    PubMed     Text format     Related articles   



  288. TSOCHATZIS EA , Germani G, Hall A, Anousou PM, et al
    Noninvasive assessment of liver fibrosis: the need for better validation.
    Hepatology. 2011;53:1781-2.
    PubMed     Text format     Related articles   



  289. MANCO M , Lo Zupone C, Latini A, Lucidi V, et al
    Noninvasive assessment of cystic fibrosis-associated liver disease with acoustic radiation force impulse imaging.
    Hepatology. 2011;53:1779-80.
    PubMed     Text format     Related articles   



    April 2011
  290. QU A , Taylor M, Xue X, Matsubara T, et al
    Hypoxia-inducible transcription factor 2alpha promotes steatohepatitis through augmenting lipid accumulation, inflammation and fibrosis.
    Hepatology. 2011 Apr 29. doi: 10.1002/hep.24400.
    PubMed     Text format     Related articles   



  291. IVERSON SV , Comstock KM, Kundert JA, Schmidt EE, et al
    Contributions of new hepatocyte lineages to liver growth, maintenance, and regeneration in mice.
    Hepatology. 2011 Apr 29. doi: 10.1002/hep.24398.
    PubMed     Text format     Related articles   



  292. BANSAL R , Prakash J, Post E, Beljaars L, et al
    A novel engineered targeted interferon gamma blocks hepatic fibrogenesis in mice.
    Hepatology. 2011 Apr 29. doi: 10.1002/hep.24395.
    PubMed     Text format     Related articles   



  293. FRANCESCHINI L , Realdon S, Marcolongo M, Mirandola S, et al
    Reciprocal interference between insulin and interferon-alpha signaling in hepatic cells: A vicious circle of clinical significance?
    Hepatology. 2011 Apr 29. doi: 10.1002/hep.24394.
    PubMed     Text format     Related articles   



  294. SHISHOVA EY , Stoll JM, Ersoy BA, Shrestha S, et al
    Genetic ablation or chemical inhibition of phosphatidylcholine transfer protein attenuates diet-induced hepatic glucose production.
    Hepatology. 2011 Apr 29. doi: 10.1002/hep.24393.
    PubMed     Text format     Related articles   



  295. MEYER ZU SCHWABEDISSEN HE , Ware JA, Finkelstein D, Chaudhry AS, et al
    Hepatic OATP transporter and thyroid hormone receptor interplay determines cholesterol and glucose homeostasis.
    Hepatology. 2011 Apr 28. doi: 10.1002/hep.24391.
    PubMed     Text format     Related articles   



  296. TARRATS N , Moles A, Morales A, Garcia-Ruiz C, et al
    Critical role of TNF-receptor 1 but not 2 in hepatic stellate cell proliferation, extracellular matrix remodeling and liver fibrogenesis.
    Hepatology. 2011 Apr 26. doi: 10.1002/hep.24388.
    PubMed     Text format     Related articles   



  297. NDONGO-THIAM N , Berthillon P, Errazuriz E, Bordes I, et al
    Long-term propagation of serum hepatitis C virus with production of enveloped HCV particles in human HepaRG hepatocytes.
    Hepatology. 2011 Apr 21. doi: 10.1002/hep.24386.
    PubMed     Text format     Related articles   



  298. KANG N , Gores G, Shah V
    Hepatic stellate cells: Partners in crime for liver metastases?
    Hepatology. 2011 Apr 21. doi: 10.1002/hep.24384.
    PubMed     Text format     Related articles   



  299. HORIGUCHI N , Gao B
    Reply to "Inflammation does not always kill hepatocytes during liver damage"
    Hepatology. 2011 Apr 21. doi: 10.1002/hep.24383.
    PubMed     Text format     Related articles   



  300. LIEN TH , Chang MH
    Reply to the letter to hepatology.
    Hepatology. 2011 Apr 21. doi: 10.1002/hep.24382.
    PubMed     Text format     Related articles   



  301. RAIMONDO G , Pollicino T, Levrero M, Craxi A, et al
    Occult hepatitis B virus infection and hepatocellular carcinoma development in patients with chronic hepatitis C.
    Hepatology. 2011 Apr 21. doi: 10.1002/hep.24379.
    PubMed     Text format     Related articles   



  302. LO GH
    An updated management of hepatocellular carcinoma.
    Hepatology. 2011 Apr 21. doi: 10.1002/hep.24378.
    PubMed     Text format     Related articles   



  303. CHACKO BK , Srivastava A, Johnson M, Benavides GA, et al
    The mitochondria-targeted ubiquinone MitoQ decreases ethanol-dependent micro and macro hepatosteatosis.
    Hepatology. 2011 Apr 21. doi: 10.1002/hep.24377.
    PubMed     Text format     Related articles   



  304. SANYAL AJ , Brunt EM, Kleiner DE, Kowdley K, et al
    Endpoints and clinical trial design for nonalcoholic steatohepatitis.
    Hepatology. 2011 Apr 21. doi: 10.1002/hep.24376.
    PubMed     Text format     Related articles   



  305. CHUNG KY , Cheng IK, Ching AK, Chu JH, et al
    Block of Proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition.
    Hepatology. 2011 Apr 21. doi: 10.1002/hep.24372.
    PubMed     Text format     Related articles   



  306. EHRHARDT M , Leidinger P, Keller A, Baumert TF, et al
    Profound differences of miRNA expression patterns in hepatocytes and hepatoma cell lines commonly used in HCV studies.
    Hepatology. 2011 Apr 18. doi: 10.1002/hep.24366.
    PubMed     Text format     Related articles   



  307. BRAILLON A
    Hepatocellular carcinoma and gene profiling: Back from perspective to reality.
    Hepatology. 2011 Apr 18. doi: 10.1002/hep.24365.
    PubMed     Text format     Related articles   



  308. LIAW YF , Raptopoulou-Gigi M, Cheinquer H, Sarin SK, et al
    Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized open-label study.
    Hepatology. 2011 Apr 18. doi: 10.1002/hep.24361.
    PubMed     Text format     Related articles    Abstract available



  309. UEKI S , Castellaneta A, Yoshida O, Ozaki K, et al
    Hepatic B7-H1 expression is essential to control cold ischemia/reperfusion injury after mouse liver transplantation.
    Hepatology. 2011 Apr 18. doi: 10.1002/hep.24360.
    PubMed     Text format     Related articles    Abstract available



  310. NAKAGAWA H , Hirata Y, Takeda K, Hayakawa Y, et al
    Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated MAPK.
    Hepatology. 2011 Apr 12. doi: 10.1002/hep.24357.
    PubMed     Text format     Related articles    Abstract available



  311. RONG G , Zhong R, Lleo A, Leung PS, et al
    Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis.
    Hepatology. 2011 Apr 12. doi: 10.1002/hep.24355.
    PubMed     Text format     Related articles    Abstract available



  312. SCHILDBERG FA , Wojtalla A, Siegmund SV, Endl E, et al
    Hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism.
    Hepatology. 2011 Apr 12. doi: 10.1002/hep.24352.
    PubMed     Text format     Related articles    Abstract available



  313. THAKUR PC , Stuckenholz C, Rivera MR, Davison JM, et al
    Lack of de novo phosphatidylinositol synthesis leads to endoplasmic reticulum stress and hepatic steatosis in cdipt-deficient zebrafish.
    Hepatology. 2011 Apr 12. doi: 10.1002/hep.24349.
    PubMed     Text format     Related articles    Abstract available



  314. CSAK T , Ganz M, Pespisa J, Kodys K, et al
    Fatty acids and endotoxin activate inflammasome in hepatocytes which release danger signals to activate immune cells in steatohepatitis.
    Hepatology. 2011 Apr 12. doi: 10.1002/hep.24341.
    PubMed     Text format     Related articles    Abstract available



  315. XIN YN , Lin ZH, Xuan SY
    Are there more factors other than hepatitis B virus-DNA level and A1762T/G1764A mutation in liver tissue that also independently predict postoperative survival in hepatocellular carcinoma?
    Hepatology. 2011 Apr 5. doi: 10.1002/hep.24211.
    PubMed     Text format     Related articles   



  316. CLEMENT S , Peyrou M, Sanchez-Pareja A, Bourgoin L, et al
    Downregulation of PTEN and IRS-1 by HCV 3a core protein triggers the formation of large lipid droplets in hepatocytes.
    Hepatology. 2011 Apr 4. doi: 10.1002/hep.24340.
    PubMed     Text format     Related articles    Abstract available



  317. WU JW , Wang SP, Alvarez F, Casavant S, et al
    Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis.
    Hepatology. 2011 Apr 4. doi: 10.1002/hep.24338.
    PubMed     Text format     Related articles    Abstract available



  318. GALBOIS A , Das V, Thabut D, Maury E, et al
    Beta-blockers have no effect on outcomes in patients with cirrhosis and severe infections.
    Hepatology. 2011;53:1412-3.
    PubMed     Text format     Related articles   



  319. KURT M
    Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites.
    Hepatology. 2011;53:1411-2.
    PubMed     Text format     Related articles   



  320. GALICHON P , Hertig A, Rondeau E, Mesnard L, et al
    Warning: Genome-wide association studies can be misleading. An example in hepatology.
    Hepatology. 2011;53:1408.
    PubMed     Text format     Related articles   



  321. HARRISON SA , Schenker S, Cusi K
    Insulin sensitizers in nonalcoholic steatohepatitis.
    Hepatology. 2011;53:1404-5.
    PubMed     Text format     Related articles   



  322. ALISON MR , Lin WR
    Hepatocyte turnover and regeneration: Virtually a virtuoso performance.
    Hepatology. 2011;53:1393-6.
    PubMed     Text format     Related articles    Abstract available



  323. LIM SO , Park YM, Kim HS, Quan X, et al
    Notch1 differentially regulates oncogenesis by wildtype p53 overexpression and p53 mutation in grade III hepatocellular carcinoma.
    Hepatology. 2011;53:1382-92.
    PubMed     Text format     Related articles    Abstract available



  324. BUTTERWORTH RF
    Hepatic encephalopathy: A central neuroinflammatory disorder?
    Hepatology. 2011;53:1372-6.
    PubMed     Text format     Related articles    Abstract available



  325. ZHANG D , Utsumi T, Huang HC, Gao L, et al
    Reticulon 4B (Nogo-B) is a novel regulator of hepatic fibrosis.
    Hepatology. 2011;53:1306-15.
    PubMed     Text format     Related articles    Abstract available



  326. OHISHI W , Fujiwara S, Cologne JB, Suzuki G, et al
    Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma.
    Hepatology. 2011;53:1237-45.
    PubMed     Text format     Related articles    Abstract available



  327. CALVISI DF , Simile MM, Ladu S, Frau M, et al
    Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.
    Hepatology. 2011;53:1226-36.
    PubMed     Text format     Related articles    Abstract available



  328. FWU CW , Chien YC, You SL, Nelson KE, et al
    Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: A cohort study of parous women in Taiwan.
    Hepatology. 2011;53:1217-25.
    PubMed     Text format     Related articles    Abstract available



  329. MIZUKOSHI E , Nakamoto Y, Arai K, Yamashita T, et al
    Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.
    Hepatology. 2011;53:1206-16.
    PubMed     Text format     Related articles    Abstract available



  330. RONOT M , Bahrami S, Calderaro J, Valla DC, et al
    Hepatocellular adenomas: Accuracy of magnetic resonance imaging and liver biopsy in subtype classification.
    Hepatology. 2011;53:1182-91.
    PubMed     Text format     Related articles    Abstract available



  331. WANG WH , Studach LL, Andrisani OM
    Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication.
    Hepatology. 2011;53:1137-47.
    PubMed     Text format     Related articles    Abstract available



  332. LANITIS A , Toso C
    Liver mass with central calcification.
    Hepatology. 2011;53:1397-8.
    PubMed     Text format     Related articles   



  333. PADDA MS , Sanchez M, Akhtar AJ, Boyer JL, et al
    Drug-induced cholestasis.
    Hepatology. 2011;53:1377-87.
    PubMed     Text format     Related articles    Abstract available



  334. JEONG WI , Park O, Suh YG, Byun JS, et al
    Suppression of innate immunity (natural killer cell/interferon-gamma) in the advanced stages of liver fibrosis in mice.
    Hepatology. 2011;53:1342-51.
    PubMed     Text format     Related articles    Abstract available



  335. WEERASINGHE SV , Moons DS, Altshuler PJ, Shah YM, et al
    Fibrinogen-gamma proteolysis and solubility dynamics during apoptotic mouse liver injury: heparin prevents and treats liver damage.
    Hepatology. 2011;53:1323-32.
    PubMed     Text format     Related articles    Abstract available



  336. CHEN F , Hori T, Ohashi N, Baine AM, et al
    Occludin is regulated by epidermal growth factor receptor activation in brain endothelial cells and brains of mice with acute liver failure.
    Hepatology. 2011;53:1294-305.
    PubMed     Text format     Related articles    Abstract available



  337. KIREVA T , Erhardt A, Tiegs G, Tilg H, et al
    Transcription factor Fra-1 induces cholangitis and liver fibrosis.
    Hepatology. 2011;53:1287-97.
    PubMed     Text format     Related articles    Abstract available



  338. BAI L , Jia Y, Viswakarma N, Huang J, et al
    Transcription coactivator mediator subunit MED1 is required for the development of fatty liver in the mouse.
    Hepatology. 2011;53:1164-74.
    PubMed     Text format     Related articles    Abstract available



  339. MCNIVEN MA , Casey CA
    Alcohol and lipid traffic don't mix.
    Hepatology. 2011;53:1073-5.
    PubMed     Text format     Related articles   



    March 2011
  340. BACON BR , Adams PC, Kowdley KV, Powell LW, et al
    Diagnosis and management of hemochromatosis: 2011 practice guidelines by the American association for the study of liver diseases.
    Hepatology. 2011 Mar 30. doi: 10.1002/hep.24330.
    PubMed     Text format     Related articles    Abstract available



  341. SCHNELLER D , Machat G, Sousek A, Proell V, et al
    p19(ARF) /p14(ARF) controls oncogenic functions of Stat3 in hepatocellular carcinoma.
    Hepatology. 2011 Mar 30. doi: 10.1002/hep.24329.
    PubMed     Text format     Related articles    Abstract available



  342. SHERMAN M
    Histological diagnosis of early hepatocellular carcinoma.
    Hepatology. 2011 Mar 30. doi: 10.1002/hep.24332.
    PubMed     Text format     Related articles   



  343. ZEMTSOVA I , Gorg B, Keitel V, Bidmon HJ, et al
    Microglia activation in hepatic encephalopathy.
    Hepatology. 2011 Mar 30. doi: 10.1002/hep.24326.
    PubMed     Text format     Related articles    Abstract available



  344. CARCHMAN EH , Rao J, Loughran PA, Rosengart MR, et al
    Heme oxygenase-1 mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis.
    Hepatology. 2011 Mar 24. doi: 10.1002/hep.24324.
    PubMed     Text format     Related articles    Abstract available



  345. GHAFFARI AA , Chow EK, Iyer SS, Deng JC, et al
    PolyI:C suppresses acetaminophen-induced hepatotoxicity independent of type I interferons and toll-like receptor 3.
    Hepatology. 2011 Mar 23. doi: 10.1002/hep.24316.
    PubMed     Text format     Related articles    Abstract available



  346. FREDRIKSSON L , Herpers B, Benedetti G, Matadin Q, et al
    Diclofenac inhibits tumor necrosis factor alpha-induced nuclear factor-kappaB activation causing synergistic hepatocyte apoptosis.
    Hepatology. 2011 Mar 23. doi: 10.1002/hep.24314.
    PubMed     Text format     Related articles    Abstract available



  347. HIKITA H , Takehara T, Kodama T, Shimizu S, et al
    Delayed-onset caspase-dependent massive hepatocyte apoptosis upon Fas activation in Bak/Bax-deficient mice.
    Hepatology. 2011 Mar 21. doi: 10.1002/hep.24305.
    PubMed     Text format     Related articles    Abstract available



  348. CHAITEERAKIJ R , Roberts LR
    Telomerase mutation: A genetic risk factor for cirrhosis.
    Hepatology. 2011 Mar 21. doi: 10.1002/hep.24304.
    PubMed     Text format     Related articles   



  349. VLACHOGIANNAKOS J , Daikos G, Thalheimer U, Burroughs A, et al
    Is bacterial DNA a better marker of bacterial translocation than endotoxin in decompensated cirrhosis?
    Hepatology. 2011 Mar 21. doi: 10.1002/hep.24303.
    PubMed     Text format     Related articles   



  350. CSAK T , Dolganiuc A, Kodys K, Nath B, et al
    Mitochondrial antiviral signaling protein defect links impaired antiviral response and liver injury in steatohepatitis in mice.
    Hepatology. 2011 Mar 21. doi: 10.1002/hep.24301.
    PubMed     Text format     Related articles    Abstract available



  351. ESPELT MV , Croci DO, Bacigalupo ML, Carabias P, et al
    Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization and in vivo tumor growth.
    Hepatology. 2011 Mar 9. doi: 10.1002/hep.24294.
    PubMed     Text format     Related articles    Abstract available



  352. OMAR HA , Chou CC, Berman-Booty LD, Ma Y, et al
    Antitumor effects of OSU-2S, a non-immunosuppressive analogue of FTY720, in hepatocellular carcinoma.
    Hepatology. 2011 Mar 9. doi: 10.1002/hep.24293.
    PubMed     Text format     Related articles    Abstract available



  353. WANG S , Huang X, Li Y, Lao H, et al
    RN181 suppressed tumor growth of hepatocellular carcinoma by inhibition of the ERK/MAPK pathway.
    Hepatology. 2011 Mar 9. doi: 10.1002/hep.24291.
    PubMed     Text format     Related articles    Abstract available



  354. BACCARANI U , Adani GL, Tavio M, Viale P, et al
    Liver transplantation for hepatocellular carcinoma (HCC): The impact of human immunodeficiency virus infection: 21 plus 13.
    Hepatology. 2011 Mar 9. doi: 10.1002/hep.24287.
    PubMed     Text format     Related articles   



  355. PAIK YH , Iwaisako K, Seki E, Inokuchi S, et al
    The nicotinamide adenine dinucleotide phosphate oxidase homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice.
    Hepatology. 2011 Mar 7. doi: 10.1002/hep.24281.
    PubMed     Text format     Related articles    Abstract available



  356. SANTANGELO L , Marchetti A, Cicchini C, Conigliaro A, et al
    The stable repression of mesenchymal program is required for hepatocyte identity: A novel role for hepatocyte nuclear factor 4alpha
    Hepatology. 2011 Mar 7. doi: 10.1002/hep.24280.
    PubMed     Text format     Related articles    Abstract available



  357. BENSADOUN P , Rodriguez C, Soulier A, Higgs M, et al
    Genetic background of hepatocyte cell lines: Are in vitro hepatitis C virus research data reliable?
    Hepatology. 2011 Mar 7. doi: 10.1002/hep.24278.
    PubMed     Text format     Related articles   



  358. BOSOI CR , Parent-Robitaille C, Anderson K, Tremblay M, et al
    AST-120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile-duct ligated rats.
    Hepatology. 2011 Mar 7. doi: 10.1002/hep.24273.
    PubMed     Text format     Related articles    Abstract available



  359. LOK AS , Everhart JE, Di Bisceglie AM, Kim HY, et al
    Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in us patients with chronic hepatitis C.
    Hepatology. 2011 Mar 3. doi: 10.1002/hep.24257.
    PubMed     Text format     Related articles    Abstract available



  360. MARONGIU F , Gramignoli R, Dorko K, Miki T, et al
    Hepatic differentiation of amniotic epithelial cells.
    Hepatology. 2011 Mar 3. doi: 10.1002/hep.24255.
    PubMed     Text format     Related articles    Abstract available



  361. YE LP , Mao XL
    Is achievement of sustained virologic response an independent predictor or a cofactor for the development of esophageal varices?
    Hepatology. 2011;53:1070-1.
    PubMed     Text format     Related articles   



  362. SCHULZE-OSTHOFF K , Bantel H
    Necrosis versus apoptosis in acetaminophen-induced hepatotoxicity.
    Hepatology. 2011;53:1070.
    PubMed     Text format     Related articles   



  363. LO GH
    Effects of beta-blockers on survival for patients with cirrhosis and refractory ascites.
    Hepatology. 2011;53:1068-9.
    PubMed     Text format     Related articles   



  364. LEWINDON PJ , Ramm GA
    Cystic fibrosis-cirrhosis, portal hypertension, and liver biopsy: Reply.
    Hepatology. 2011;53:1065-6.
    PubMed     Text format     Related articles   



  365. WITTERS P , Libbrecht L, Roskams T, Boeck KD, et al
    Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease.
    Hepatology. 2011;53:1064-5.
    PubMed     Text format     Related articles   



  366. JORGE A M , Hashem B el-S
    Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the american association for the study of liver diseases.
    Hepatology. 2011;53:1060-1.
    PubMed     Text format     Related articles   



  367. MANCO M , Alisi A, Mosca A, Nobili V, et al
    The wide spectrum of hepatic iron overload.
    Hepatology. 2011;53:1057-8.
    PubMed     Text format     Related articles   



  368. TURNER R , Lozoya O, Wang Y, Cardinale V, et al
    Human hepatic stem cell and maturational liver lineage biology.
    Hepatology. 2011;53:1035-45.
    PubMed     Text format     Related articles    Abstract available



  369. BRUIX J , Sherman M
    Management of hepatocellular carcinoma: An update.
    Hepatology. 2011;53:1020-2.
    PubMed     Text format     Related articles   



  370. CHOU HS , Hsieh CC, Yang HR, Wang L, et al
    Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice.
    Hepatology. 2011;53:1007-19.
    PubMed     Text format     Related articles    Abstract available



  371. GOMEZ-HURTADO I , Zapater P, Bellot P, Pascual S, et al
    Interleukin-10-mediated heme oxygenase 1-induced underlying mechanism in inflammatory down-regulation by norfloxacin in cirrhosis.
    Hepatology. 2011;53:935-44.
    PubMed     Text format     Related articles    Abstract available



  372. WU SJ , Yang YH, Tsuneyama K, Leung PS, et al
    Innate immunity and primary biliary cirrhosis: Activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis.
    Hepatology. 2011;53:915-25.
    PubMed     Text format     Related articles    Abstract available



  373. ALEKSIC K , Lackner C, Geigl JB, Schwarz M, et al
    Evolution of genomic instability in diethylnitrosamine-induced hepatocarcinogenesis in mice.
    Hepatology. 2011;53:895-904.
    PubMed     Text format     Related articles    Abstract available



  374. KENG VW , Tschida BR, Bell JB, Largaespada DA, et al
    Modeling hepatitis B virus X-induced hepatocellular carcinoma in mice with the sleeping beauty transposon system.
    Hepatology. 2011;53:781-90.
    PubMed     Text format     Related articles    Abstract available



  375. CALVISI DF
    Of mice and men: The nonrandom genomic instability in hepatocarcinogenesis.
    Hepatology. 2011;53:723-5.
    PubMed     Text format     Related articles   



  376. LI T , Zhi XT, Hu SY
    Congenital portal venous system aneurysms associated with caput medusae.
    Hepatology. 2011;53:1052-3.
    PubMed     Text format     Related articles   



  377. AYONRINDE OT , Olynyk JK, Beilin LJ, Mori TA, et al
    Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.
    Hepatology. 2011;53:800-9.
    PubMed     Text format     Related articles    Abstract available



  378. BRUNT EM , Gores G
    "Pardon the interruption": comments on the International Liver Cancer Association Fourth Annual Conference, 2010. Is there really no role for liver biopsy interpretation in liver cancer?
    Hepatology. 2011;53:721-2.
    PubMed     Text format     Related articles   



  379. BRUNT EM , Kleiner DE, Wilson LA, Belt P, et al
    Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.
    Hepatology. 2011;53:810-20.
    PubMed     Text format     Related articles    Abstract available



  380. SHUKLA V , Cuenin C, Dubey N, Herceg Z, et al
    Loss of histone acetyltransferase cofactor transformation/transcription domain-associated protein impairs liver regeneration after toxic injury.
    Hepatology. 2011;53:954-63.
    PubMed     Text format     Related articles    Abstract available



  381. BAE SH , Sung SH, Cho EJ, Lee SK, et al
    Concerted action of sulfiredoxin and peroxiredoxin I protects against alcohol-induced oxidative injury in mouse liver.
    Hepatology. 2011;53:945-53.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  382. QIU W , Zhang J, Dekker MJ, Wang H, et al
    Hepatic autophagy mediates ER stress-induced degradation of misfolded apolipoprotein B.
    Hepatology. 2011 Feb 28. doi: 10.1002/hep.24269.
    PubMed     Text format     Related articles    Abstract available



  383. YOUNOSSI Z , Stepanova M, Rafiq N, Makhlouf H, et al
    Pathologic criteria for non-alcoholic steatohepatitis (NASH): Inter-protocol agreement and ability to predict liver-related mortality.
    Hepatology. 2011 Feb 28. doi: 10.1002/hep.24268.
    PubMed     Text format     Related articles    Abstract available



  384. VALENTI L , Colombo M, Fargion S
    PNPLA3 genotype and hepatocellular carcinoma in chronic hepatitis C.
    Hepatology. 2011 Feb 28. doi: 10.1002/hep.24265.
    PubMed     Text format     Related articles   



  385. DUCLOS-VALLEE JC , Adam R, Vibert E, Samuel D, et al
    Answer to Fabrizio Di Benedetto et al. about HEP-10-0910.R2 "liver transplantation for hepatocellular carcinoma: The impact of human immunodeficiency virus infection"
    Hepatology. 2011 Feb 28. doi: 10.1002/hep.24264.
    PubMed     Text format     Related articles   



  386. CHEN YL , Lv J, Ye XL, Sun MY, et al
    Sorafenib suppresses TGF-beta1-induced epithelial-to-mesenchymal transition and apoptosis in mouse hepatocytes.
    Hepatology. 2011 Feb 25. doi: 10.1002/hep.24254.
    PubMed     Text format     Related articles    Abstract available



  387. PARK SW , Kim M, Brown KM, D'Agati VD, et al
    Paneth cell-derived IL-17A causes multi-organ dysfunction after hepatic ischemia and reperfusion injury.
    Hepatology. 2011 Feb 25. doi: 10.1002/hep.24253.
    PubMed     Text format     Related articles    Abstract available



  388. GOLFIERI R , Cappelli A, Cucchetti A, Piscaglia F, et al
    Efficacy of selective transarterial chemoembolization in obtaining tumor necrosis in small (<5 cm) hepatocellular carcinomas.
    Hepatology. 2011 Feb 23. doi: 10.1002/hep.24246.
    PubMed     Text format     Related articles    Abstract available



  389. CORRADINI SG , Burza MA, Molinaro A, Romeo S, et al
    Patatin-like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma.
    Hepatology. 2011 Feb 23. doi: 10.1002/hep.24244.
    PubMed     Text format     Related articles   



  390. HAUFE S , Engeli S, Kast P, Bohnke J, et al
    Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects.
    Hepatology. 2011 Feb 15. doi: 10.1002/hep.24242.
    PubMed     Text format     Related articles    Abstract available



  391. SHIMODA S , Harada K, Niiro H, Shirabe K, et al
    Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis.
    Hepatology. 2011 Feb 14. doi: 10.1002/hep.24194.
    PubMed     Text format     Related articles    Abstract available



  392. JAESCHKE H , Williams CD, Farhood A
    No evidence for caspase-dependent apoptosis in acetaminophen hepatotoxicity.
    Hepatology. 2011;53:718-9.
    PubMed     Text format     Related articles   



  393. THABUT D , Moreau R, Lebrec D
    Noninvasive assessment of portal hypertension in patients with cirrhosis.
    Hepatology. 2011;53:683-94.
    PubMed     Text format     Related articles    Abstract available



  394. FIDLER J , Hough D
    Hepatocyte-specific magnetic resonance Imaging contrast agents.
    Hepatology. 2011;53:678-82.
    PubMed     Text format     Related articles   



  395. MONIAUX N , Song H, Darnaud M, Garbin K, et al
    Human hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein cures fas-induced acute liver failure in mice by attenuating free-radical damage in injured livers.
    Hepatology. 2011;53:618-27.
    PubMed     Text format     Related articles    Abstract available



  396. DONTHAMSETTY S , Bhave VS, Kliment CS, Bowen WC, et al
    Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene.
    Hepatology. 2011;53:587-95.
    PubMed     Text format     Related articles    Abstract available



  397. MONTAGNESE S , Biancardi A, Schiff S, Carraro P, et al
    Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis.
    Hepatology. 2011;53:558-66.
    PubMed     Text format     Related articles    Abstract available



  398. HE H , Mennone A, Boyer JL, Cai SY, et al
    Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells.
    Hepatology. 2011;53:548-57.
    PubMed     Text format     Related articles    Abstract available



  399. DHIRAPONG A , Lleo A, Yang GX, Tsuneyama K, et al
    B cell depletion therapy exacerbates murine primary biliary cirrhosis.
    Hepatology. 2011;53:527-35.
    PubMed     Text format     Related articles    Abstract available



  400. ZHAO Y , Wang X, Wang T, Hu X, et al
    Acetylcholinesterase, a key prognostic predictor for hepatocellular carcinoma, suppresses cell growth and induces chemosensitization.
    Hepatology. 2011;53:493-503.
    PubMed     Text format     Related articles    Abstract available



  401. FENG YX , Wang T, Deng YZ, Yang P, et al
    Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model.
    Hepatology. 2011;53:483-92.
    PubMed     Text format     Related articles    Abstract available



  402. VIBERT E , Duclos-Vallee JC, Ghigna MR, Hoti E, et al
    Liver transplantation for hepatocellular carcinoma: The impact of human immunodeficiency virus infection.
    Hepatology. 2011;53:475-82.
    PubMed     Text format     Related articles    Abstract available



  403. KOZLITINA J , Boerwinkle E, Cohen JC, Hobbs HH, et al
    Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance.
    Hepatology. 2011;53:467-74.
    PubMed     Text format     Related articles    Abstract available



  404. GUAN M , Qu L, Tan W, Chen L, et al
    Hepatocyte nuclear factor-4 alpha regulates liver triglyceride metabolism in part through secreted phospholipase A(2) GXIIB.
    Hepatology. 2011;53:458-66.
    PubMed     Text format     Related articles    Abstract available



  405. NELSON JE , Wilson L, Brunt EM, Yeh MM, et al
    Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.
    Hepatology. 2011;53:448-57.
    PubMed     Text format     Related articles    Abstract available



  406. LEVEEN P , Kotarsky H, Morgelin M, Karikoski R, et al
    The GRACILE mutation introduced into Bcs1l causes postnatal complex III deficiency: A viable mouse model for mitochondrial hepatopathy.
    Hepatology. 2011;53:437-47.
    PubMed     Text format     Related articles    Abstract available



  407. SHRIVASTAVA S , Raychoudhuri A, Steele R, Ray R, et al
    Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes.
    Hepatology. 2011;53:406-14.
    PubMed     Text format     Related articles    Abstract available



  408. MACHADO MV , Cortez-Pinto H
    Osteopontin: A missing link between hedgehog signaling and fibrosis in nonalcoholic steatohepatitis.
    Hepatology. 2011;53:382-4.
    PubMed     Text format     Related articles   



  409. SHARMA P , Singh S, Sarin SK
    Hyponatremia in patients with acute variceal bleeding treated with terlipressin.
    Hepatology. 2011;53:714.
    PubMed     Text format     Related articles   



  410. PETRASEK J , Dolganiuc A, Csak T, Nath B, et al
    Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells.
    Hepatology. 2011;53:649-60.
    PubMed     Text format     Related articles    Abstract available



  411. KHANDELWAL N , James LP, Sanders C, Larson AM, et al
    Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure.
    Hepatology. 2011;53:567-76.
    PubMed     Text format     Related articles    Abstract available



  412. MISHRA L
    Health care reform: how personalized medicine could help bundling of care for liver diseases.
    Hepatology. 2011;53:379-81.
    PubMed     Text format     Related articles   



  413. JONES DE , Newton JL
    The complexity of fatigue.
    Hepatology. 2011;53:717-8.
    PubMed     Text format     Related articles   



    January 2011
  414. ALVES TC , Befroy DE, Kibbey RG, Kahn M, et al
    Regulation of hepatic fat and glucose oxidation in rats with lipid-induced hepatic insulin resistance.
    Hepatology. 2011 Jan 11. doi: 10.1002/hep.24170.
    PubMed     Text format     Related articles    Abstract available



  415. SENZOLO M , Nadal E, Cholongitas E, Burroughs AK, et al
    Is hydrophobia necessary for the hepatologist prescribing nonselective beta-blockers in cirrhosis?
    Hepatology. 2011 Jan 10. doi: 10.1002/hep.24176.
    PubMed     Text format     Related articles   



  416. WENG H , Li H, Dooley S
    Inflammation does not always kill hepatocytes during liver damage.
    Hepatology. 2011 Jan 10. doi: 10.1002/hep.24166.
    PubMed     Text format     Related articles   



  417. JONES DE , Mells G
    The genetics of primary biliary cirrhosis: The revolution moves on.
    Hepatology. 2011;53:362-4.
    PubMed     Text format     Related articles   



  418. WANG Y , Cui CB, Yamauchi M, Miguez P, et al
    Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds.
    Hepatology. 2011;53:293-305.
    PubMed     Text format     Related articles    Abstract available



  419. CLARKE C , Kuboki S, Sakai N, Kasten KR, et al
    CXC chemokine receptor-1 is expressed by hepatocytes and regulates liver recovery after hepatic ischemia/reperfusion injury.
    Hepatology. 2011;53:261-71.
    PubMed     Text format     Related articles    Abstract available



  420. MARTIN J , Romanque P, Maurhofer O, Schmitter K, et al
    Ablation of the tumor suppressor histidine triad nucleotide binding protein 1 is protective against hepatic ischemia/reperfusion injury.
    Hepatology. 2011;53:243-52.
    PubMed     Text format     Related articles    Abstract available



  421. KORNEK M , Popov Y, Libermann TA, Afdhal NH, et al
    Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells.
    Hepatology. 2011;53:230-42.
    PubMed     Text format     Related articles    Abstract available



  422. LEWINDON PJ , Shepherd RW, Walsh MJ, Greer RM, et al
    Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy.
    Hepatology. 2011;53:193-201.
    PubMed     Text format     Related articles    Abstract available



  423. FU J , Chen Y, Cao J, Luo T, et al
    p28(GANK) overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1alpha pathways.
    Hepatology. 2011;53:181-92.
    PubMed     Text format     Related articles    Abstract available



  424. CHEN MC , Chen CH, Chuang HC, Kulp SK, et al
    Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase IIalpha degradation in hepatocellular carcinoma cells.
    Hepatology. 2011;53:148-59.
    PubMed     Text format     Related articles    Abstract available



  425. ZHANG Z , Zhang S, Zou Z, Shi J, et al
    Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients.
    Hepatology. 2011;53:73-85.
    PubMed     Text format     Related articles    Abstract available



  426. KRAG A , Moller S, Bendtsen F
    Hyponatremia in patients treated with terlipressin: mechanisms and implications for clinical practice.
    Hepatology. 2011;53:368-9.
    PubMed     Text format     Related articles   



  427. YAN AW , Fouts DE, Brandl J, Starkel P, et al
    Enteric dysbiosis associated with a mouse model of alcoholic liver disease.
    Hepatology. 2011;53:96-105.
    PubMed     Text format     Related articles    Abstract available



  428. STICKEL F , Buch S, Lau K, zu Schwabedissen HM, et al
    Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians.
    Hepatology. 2011;53:86-95.
    PubMed     Text format     Related articles    Abstract available



  429. CHAU BN , Brenner DA
    What goes up must come down: the emerging role of microRNA in fibrosis.
    Hepatology. 2011;53:4-6.
    PubMed     Text format     Related articles   



  430. LEE YM , Lim JH, Yoon H, Chun YS, et al
    Antihepatoma activity of chaetocin due to deregulated splicing of hypoxia-inducible factor 1alpha pre-mRNA in mice and in vitro.
    Hepatology. 2011;53:171-80.
    PubMed     Text format     Related articles    Abstract available



  431. LEE TK , Castilho A, Cheung VC, Tang KH, et al
    Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation.
    Hepatology. 2011;53:160-70.
    PubMed     Text format     Related articles    Abstract available



  432. RODERBURG C , Urban GW, Bettermann K, Vucur M, et al
    Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis.
    Hepatology. 2011;53:209-18.
    PubMed     Text format     Related articles    Abstract available



  433. SHEN L
    Tea intake and liver diseases.
    Hepatology. 2011;53:373-4.
    PubMed     Text format     Related articles   



  434. TARGHER G , Day CP
    Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease.
    Hepatology. 2011;53:375.
    PubMed     Text format     Related articles   



    December 2010
  435. LEVEEN P , Kotarsky H, Morgelin M, Karikoski R, et al
    The GRACILE mutation introduced into Bcs1l causes postnatal complex III deficiency: A viable mouse model for mitochondrial hepatopathy.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  436. LO GH
    Effects of beta-blockers on survival for patients with cirrhosis and refractory ascites.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  437. ORELLANA-GAVALDA JM , Herrero L, Malandrino MI, Paneda A, et al
    Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation.
    Hepatology. 2010 Dec 22. doi: 10.1002/hep.24140.
    PubMed     Text format     Related articles    Abstract available



  438. MCGILL MR , Yan HM, Ramachandran A, Murray GJ, et al
    HepaRG cells: A human model to study mechanisms of acetaminophen hepatotoxicity.
    Hepatology. 2010 Dec 17. doi: 10.1002/hep.24132.
    PubMed     Text format     Related articles    Abstract available



  439. LIU W , Li X, Chu ES, Go MY, et al
    Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway.
    Hepatology. 2010 Dec 17. doi: 10.1002/hep.24124.
    PubMed     Text format     Related articles    Abstract available



  440. COLECCHIA A , Montrone L, Scaioli E, Festi D, et al
    Percutaneous liver biopsy in the clinical management of hepatocellular carcinoma: Back to the future.
    Hepatology. 2010 Dec 17. doi: 10.1002/hep.24130.
    PubMed     Text format     Related articles   



  441. ASAHINA K , Zhou B, Pu WT, Tsukamoto H, et al
    Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver.
    Hepatology. 2010 Dec 14. doi: 10.1002/hep.24119.
    PubMed     Text format     Related articles    Abstract available



  442. GITLIN N
    Treatment of hepatic encephalopathy with rifaximin: More to think about.
    Hepatology. 2010 Dec 14. doi: 10.1002/hep.24112.
    PubMed     Text format     Related articles   



  443. YOON SM , Gerasimidou D, Kuwahara R, Hytiroglou P, et al
    Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans.
    Hepatology. 2010 Dec 14. doi: 10.1002/hep.24122.
    PubMed     Text format     Related articles    Abstract available



  444. JUNG KS , Kim SU, Ahn SH, Park YN, et al
    Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).
    Hepatology. 2010 Dec 14. doi: 10.1002/hep.24121.
    PubMed     Text format     Related articles    Abstract available



  445. LI T , Matozel M, Boehme S, Kong B, et al
    Overexpression of cholesterol 7alpha-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis.
    Hepatology. 2010 Dec 14. doi: 10.1002/hep.24107.
    PubMed     Text format     Related articles    Abstract available



  446. SCHRADER J , Gordon-Walker TT, Aucott RL, van Deemter M, et al
    Matrix stiffness modulates proliferation, chemotherapeutic response and dormancy in hepatocellular carcinoma cells.
    Hepatology. 2010 Dec 14. doi: 10.1002/hep.24108.
    PubMed     Text format     Related articles    Abstract available



  447. VON FROWEIN J , Pagel P, Kappler R, Schweinitz DV, et al
    MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma.
    Hepatology. 2010 Dec 13. doi: 10.1002/hep.24125.
    PubMed     Text format     Related articles    Abstract available



  448. YANG H , Zhan Q, Wan YJ
    Enrichment of Nur77 mediated by retinoic acid receptor beta leads to apoptosis of human hepatocellular carcinoma cells induced by fenretinide and histone deacetylase inhibitors.
    Hepatology. 2010 Dec 7. doi: 10.1002/hep.24101.
    PubMed     Text format     Related articles    Abstract available



  449. GAUGLHOFER C , Sagmeister S, Schrottmaier W, Fischer C, et al
    Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis.
    Hepatology. 2010 Dec 6. doi: 10.1002/hep.24099.
    PubMed     Text format     Related articles    Abstract available



  450. MACARON C , Hanouneh IA, Zein NN
    Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis.
    Hepatology. 2010;52:2240.
    PubMed     Text format     Related articles   



  451. SHACKEL NA
    The balancing act of hepatocyte apoptosis.
    Hepatology. 2010;52:2231-3.
    PubMed     Text format     Related articles    Abstract available



  452. RATZIU V , Caldwell S, Neuschwander-Tetri BA
    Therapeutic trials in nonalcoholic steatohepatitis: Insulin sensitizers and related methodological issues.
    Hepatology. 2010;52:2206-15.
    PubMed     Text format     Related articles    Abstract available



  453. UBEDA M , Munoz L, Borrero MJ, Diaz D, et al
    Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis.
    Hepatology. 2010;52:2086-95.
    PubMed     Text format     Related articles    Abstract available



  454. CLIFFORD RJ , Zhang J, Meerzaman DM, Lyu MS, et al
    Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma.
    Hepatology. 2010;52:2034-43.
    PubMed     Text format     Related articles    Abstract available




  455. 2010 Hepatology referees (Volumes 51 and 52).
    Hepatology. 2010;52:2251-4.
    PubMed     Text format     Related articles   



  456. MACARON C , Hanouneh IA, Zein NN
    Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis.
    Hepatology. 2010;52:2240.
    PubMed     Text format     Related articles   



  457. SHACKEL NA
    The balancing act of hepatocyte apoptosis.
    Hepatology. 2010;52:2231-3.
    PubMed     Text format     Related articles    Abstract available



  458. RATZIU V , Caldwell S, Neuschwander-Tetri BA
    Therapeutic trials in nonalcoholic steatohepatitis: Insulin sensitizers and related methodological issues.
    Hepatology. 2010;52:2206-15.
    PubMed     Text format     Related articles    Abstract available



  459. UBEDA M , Munoz L, Borrero MJ, Diaz D, et al
    Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis.
    Hepatology. 2010;52:2086-95.
    PubMed     Text format     Related articles    Abstract available



  460. CLIFFORD RJ , Zhang J, Meerzaman DM, Lyu MS, et al
    Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma.
    Hepatology. 2010;52:2034-43.
    PubMed     Text format     Related articles    Abstract available



  461. DRENTH JP , Chrispijn M, Nagorney DM, Kamath PS, et al
    Medical and surgical treatment options for polycystic liver disease.
    Hepatology. 2010;52:2223-30.
    PubMed     Text format     Related articles   



  462. HUNT CM
    Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug-induced liver injury: a systematic review.
    Hepatology. 2010;52:2216-22.
    PubMed     Text format     Related articles   



  463. THEVANANTHER S
    Adipose to the rescue: peripheral fat fuels liver regeneration.
    Hepatology. 2010;52:1875-6.
    PubMed     Text format     Related articles   



  464. ROSENCRANTZ RA , Schilsky ML
    Mining for a diagnosis of Wilson's disease in children: genetics, score, and ore.
    Hepatology. 2010;52:1872-4.
    PubMed     Text format     Related articles   



  465. GAZIT V , Weymann A, Hartman E, Finck BN, et al
    Liver regeneration is impaired in lipodystrophic fatty liver dystrophy mice.
    Hepatology. 2010;52:2109-17.
    PubMed     Text format     Related articles    Abstract available



  466. MARTINEZ-CLEMENTE M , Ferre N, Titos E, Horrillo R, et al
    Disruption of the 12/15-lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver disease.
    Hepatology. 2010;52:1980-91.
    PubMed     Text format     Related articles    Abstract available



  467. NICASTRO E , Ranucci G, Vajro P, Vegnente A, et al
    Re-evaluation of the diagnostic criteria for Wilson disease in children with mild liver disease.
    Hepatology. 2010;52:1948-56.
    PubMed     Text format     Related articles    Abstract available



  468. REUBEN A , Koch DG, Lee WM
    Drug-induced acute liver failure: results of a U.S. multicenter, prospective study.
    Hepatology. 2010;52:2065-76.
    PubMed     Text format     Related articles    Abstract available



  469. ZHANG X , Tachibana S, Wang H, Hisada M, et al
    Interleukin-6 is an important mediator for mitochondrial DNA repair after alcoholic liver injury in mice.
    Hepatology. 2010;52:2137-47.
    PubMed     Text format     Related articles    Abstract available



  470. SOOKOIAN S , Rosselli MS, Gemma C, Burgueno AL, et al
    Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor gamma coactivator 1alpha promoter.
    Hepatology. 2010;52:1992-2000.
    PubMed     Text format     Related articles    Abstract available



  471. DUSEJA A , Sharma B, Kumar A, Kapil S, et al
    Nonalcoholic fatty liver in a developing country is responsible for significant liver disease.
    Hepatology. 2010;52:2248-9.
    PubMed     Text format     Related articles   



    November 2010
  472. WANG Y , Guo Y, Wang F, Sun S, et al
    Pathogen DNA also contributes to interferon regulatory factor 3 activation in hepatic cells: Implications for alcoholic liver diseases.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  473. KENG VW , Tschida BR, Bell JB, Largaespada DA, et al
    Modeling hepatitis B virus X-induced hepatocellular carcinoma in mice with the sleeping beauty transposon system.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  474. MONIAUX N , Song H, Darnaud M, Garbin K, et al
    Human hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein cures fas-induced acute liver failure in mice by attenuating free-radical damage in injured livers.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  475. HSIEH SY , He JR, Hsu CY, Chen WJ, et al
    Constitutive activation of the neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to intrahepatic invasion and early recurrence of human hepatoma.
    Hepatology. 2010 Nov 19. doi: 10.1002/hep.24083.
    PubMed     Text format     Related articles    Abstract available



  476. ZHAO Y , Wang X, Wang T, Hu X, et al
    Acetylcholinesterase, a key prognostic predictor for hepatocellular carcinoma, suppresses cell growth and induces chemosensitization.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  477. KOZLITINA J , Boerwinkle E, Cohen JC, Hobbs HH, et al
    Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  478. SHRIVASTAVA S , Raychoudhuri A, Steele R, Ray R, et al
    Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  479. VIBERT E , Duclos-Vallee JC, Ghigna MR, Hoti E, et al
    Liver transplantation for hepatocellular carcinoma: The impact of human immunodeficiency virus infection.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  480. GUAN M , Qu L, Tan W, Chen L, et al
    Hepatocyte nuclear factor-4 alpha regulates liver triglyceride metabolism in part through secreted phospholipase A(2) GXIIB.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  481. TALWALKAR JA
    Time trends in hospitalization and discharge status for cirrhosis and portal hypertension in the united states.
    Hepatology. 2010;52:1862.
    PubMed     Text format     Related articles   



  482. TALWALKAR JA
    Defining the quality characteristics of endoscopy for acute variceal hemorrhage in cirrhosis.
    Hepatology. 2010;52:1850-1.
    PubMed     Text format     Related articles   



  483. ROSSLE M , Grandt D
    Early transjugular intrahepatic portosystemic shunt in patients with cirrhosis and variceal bleeding.
    Hepatology. 2010;52:1847-50.
    PubMed     Text format     Related articles   



  484. KARLMARK KR , Zimmermann HW, Roderburg C, Gassler N, et al
    The fractalkine receptor CX(3)CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes.
    Hepatology. 2010;52:1769-82.
    PubMed     Text format     Related articles    Abstract available



  485. HILGARD P , Hamami M, Fouly AE, Scherag A, et al
    Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.
    Hepatology. 2010;52:1741-9.
    PubMed     Text format     Related articles    Abstract available



  486. ZENG C , Wang R, Li D, Lin XJ, et al
    A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.
    Hepatology. 2010;52:1702-12.
    PubMed     Text format     Related articles    Abstract available



  487. VITAGLIONE P , Morisco F, Mazzone G, Amoruso DC, et al
    Coffee reduces liver damage in a rat model of steatohepatitis: The underlying mechanisms and the role of polyphenols and melanoidins.
    Hepatology. 2010;52:1652-61.
    PubMed     Text format     Related articles    Abstract available



  488. TILG H , Moschen AR
    Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.
    Hepatology. 2010;52:1836-46.
    PubMed     Text format     Related articles    Abstract available



  489. YU JH , Zhu BM, Wickre M, Riedlinger G, et al
    The transcription factors signal transducer and activator of transcription 5A (STAT5A) and STAT5B negatively regulate cell proliferation through the activation of cyclin-dependent kinase inhibitor 2b (Cdkn2b) and Cdkn1a expression.
    Hepatology. 2010;52:1808-18.
    PubMed     Text format     Related articles    Abstract available



  490. DENK GU , Maitz S, Wimmer R, Rust C, et al
    Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
    Hepatology. 2010;52:1758-68.
    PubMed     Text format     Related articles    Abstract available



  491. KULIK L
    Is radioembolization ready for the barcelona clinic liver cancer staging system?
    Hepatology. 2010;52:1528-30.
    PubMed     Text format     Related articles   



  492. THERNEAU T
    Working with a gold-plated standard.
    Hepatology. 2010;52:1527.
    PubMed     Text format     Related articles   



  493. WAN L , Tsai CH, Hsu CM, Huang CC, et al
    Mutation analysis and characterization of alternative splice variants of the Wilson disease gene ATP7B.
    Hepatology. 2010;52:1662-70.
    PubMed     Text format     Related articles    Abstract available



  494. NOLAN JP
    The role of intestinal endotoxin in liver injury: a long and evolving history.
    Hepatology. 2010;52:1829-35.
    PubMed     Text format     Related articles    Abstract available



  495. PACIFICO L , Anania C, Martino F, Cantisani V, et al
    Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease.
    Hepatology. 2010;52:1643-51.
    PubMed     Text format     Related articles    Abstract available



  496. LIANG L , Wong CM, Ying Q, Fan DN, et al
    MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2.
    Hepatology. 2010;52:1731-40.
    PubMed     Text format     Related articles    Abstract available



  497. XU CF , Yu CH, Xu L, Sa XY, et al
    Hypouricemic therapy: a novel potential therapeutic option for nonalcoholic fatty liver disease.
    Hepatology. 2010;52:1865-6.
    PubMed     Text format     Related articles   



  498. SHEN L
    Suggestion of a dual-functional agent for future trials in nonalcoholic fatty liver disease.
    Hepatology. 2010;52:1866-7.
    PubMed     Text format     Related articles   



    October 2010
  499. GALBOIS A , Das V, Thabut D, Maury E, et al
    Beta-blockers have no effect on outcomes in patients with cirrhosis and severe infections.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  500. KURT M
    Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  501. HE H , Mennone A, Boyer JL, Cai SY, et al
    combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  502. MONTAGNESE S , Biancardi A, Schiff S, Carraro P, et al
    Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  503. DHIRAPONG A , Lleo A, Yang GX, Tsuneyama K, et al
    B cell depletion therapy exacerbates murine primary biliary cirrhosis.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  504. DONTHAMSETTY S , Bhave VS, Kliment CS, Bowen WC, et al
    Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  505. NELSON JE , Wilson L, Brunt EM, Yeh MM, et al
    Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  506. MARRERO JA , El-Serag HB
    Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the american association for the study of liver diseases.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  507. ALBILLOS A , Zamora J
    Beta-blockers in patients with cirrhosis and refractory ascites.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  508. CLARKE C , Kuboki S, Sakai N, Kasten KR, et al
    CXC chemokine receptor-1 is expressed by hepatocytes and regulates liver recovery after hepatic ischemia/reperfusion injury.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  509. YE LP , Mao XL
    Is achievement of sustained virologic response an independent predictor or a cofactor for the development of esophageal varices?
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  510. SCHULZE-OSTHOFF K , Bantel H
    Necrosis versus apoptosis in acetaminophen-induced hepatotoxicity.
    Hepatology. 2010.
    PubMed     Text format     Related articles   




  511. Abstracts of the American Association for the Study of Liver Diseases 61st Annual Meeting and Postgraduate Course. October 29-November 2, 2010. Boston, Massachusetts, USA.
    Hepatology. 2010;52 Suppl:320A-1291A.
    PubMed     Text format     Related articles   



  512. BROWNING JD , Cohen JC, Hobbs HH
    Patatin-like phospholipase domain-containing 3 and the pathogenesis and progression of pediatric nonalcoholic fatty liver disease.
    Hepatology. 2010;52:1189-92.
    PubMed     Text format     Related articles   



  513. KI SH , Park O, Zheng M, Morales-Ibanez O, et al
    Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3.
    Hepatology. 2010;52:1291-300.
    PubMed     Text format     Related articles    Abstract available



  514. JI H , Shen X, Gao F, Ke B, et al
    Programmed death-1/B7-H1 negative costimulation protects mouse liver against ischemia and reperfusion injury.
    Hepatology. 2010;52:1380-9.
    PubMed     Text format     Related articles    Abstract available



  515. BAJAJ JS , Riggio O
    Drug therapy: rifaximin.
    Hepatology. 2010;52:1484-8.
    PubMed     Text format     Related articles   



  516. YU LX , Yan HX, Liu Q, Yang W, et al
    Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents.
    Hepatology. 2010;52:1322-33.
    PubMed     Text format     Related articles    Abstract available



  517. SANTORO N , Kursawe R, D'Adamo E, Dykas DJ, et al
    A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents.
    Hepatology. 2010;52:1281-90.
    PubMed     Text format     Related articles    Abstract available



  518. JI HF , Shen L
    Uric acid potentially links fatty liver and high blood pressure.
    Hepatology. 2010;52:1518-9.
    PubMed     Text format     Related articles   



  519. AOYAMA T , Inokuchi S, Brenner DA, Seki E, et al
    CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice.
    Hepatology. 2010;52:1390-400.
    PubMed     Text format     Related articles    Abstract available



  520. SPINZI G , Terreni N
    Health-related quality of life and sorafenib.
    Hepatology. 2010;52:1523.
    PubMed     Text format     Related articles   



  521. WHITE JS
    Therapeutic interventions for fructose-induced fatty liver disease are premature.
    Hepatology. 2010;52:1526.
    PubMed     Text format     Related articles   



  522. COLE LK , Jacobs RL, Vance DE
    Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis.
    Hepatology. 2010;52:1258-65.
    PubMed     Text format     Related articles    Abstract available



  523. VALENTI L , Alisi A, Galmozzi E, Bartuli A, et al
    I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
    Hepatology. 2010;52:1274-80.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  524. BANAUDHA K , Kaliszewski M, Korolnek T, Florea L, et al
    MicroRNA silencing of tumor suppressor DLC-1 promotes efficient hepatitis C virus replication in primary human hepatocytes.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  525. LEWINDON PJ , Shepherd RW, Walsh MJ, Greer RM, et al
    Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  526. FU J , Chen Y, Cao J, Luo T, et al
    p28(GANK) overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1alpha pathways.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  527. SCHMICH K , Schlatter R, Corazza N, Ferreira KS, et al
    Tumor necrosis factor alpha sensitizes primary murine hepatocytes to Fas/CD95-induced apoptosis in a Bim- and Bid-dependent manner.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  528. ALISI A , Panera N, Balsano C, Nobili V, et al
    Activation of the endotoxin/toll-like receptor 4 pathway: The way to go from nonalcoholic steatohepatitis up to hepatocellular carcinoma.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  529. ONG KT , Mashek MT, Bu SY, Greenberg AS, et al
    Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  530. XI L , Xiao C, Bandsma RH, Naples M, et al
    C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: Role of mitogen-activated protein kinases.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  531. WANG Y , Cui CB, Yamauchi M, Miguez P, et al
    Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  532. KORNEK M , Popov Y, Libermann TA, Afdhal NH, et al
    Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  533. SYN WK , Choi SS, Liaskou E, Karaca GF, et al
    Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  534. BLECHACZ B , Gores GJ
    Positron emission tomography scan for a hepatic mass.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  535. CSANAKY IL , Lu H, Zhang Y, Ogura K, et al
    Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: Studies in Oatp1b2-null mice.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  536. JIN Z , Sun R, Wei H, Gao X, et al
    Accelerated liver fibrosis in hepatitis B virus transgenic mice: Involvement of natural killer T cells.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  537. ZHANG Z , Zhang S, Zou Z, Shi J, et al
    Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  538. MARTIN J , Romanque P, Maurhofer O, Schmitter K, et al
    Ablation of the tumor suppressor histidine triad nucleotide binding protein 1 is protective against hepatic ischemia/reperfusion injury.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  539. ROSSI S , Ravetta V, Rosa L, Ghittoni G, et al
    Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: A long-term cohort study.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  540. ROWE IA
    Sorafenib therapy in patients with hepatocellular carcinoma before liver transplantation.
    Hepatology. 2010;52:1171-2.
    PubMed     Text format     Related articles   



  541. LUEDDE T
    MicroRNA-151 and its hosting gene FAK (focal adhesion kinase) regulate tumor cell migration and spreading of hepatocellular carcinoma.
    Hepatology. 2010;52:1162-4.
    PubMed     Text format     Related articles    Abstract available



  542. NUNEZ M
    Clinical syndromes and consequences of antiretroviral-related hepatotoxicity.
    Hepatology. 2010;52:1143-55.
    PubMed     Text format     Related articles    Abstract available



  543. LIU B , Bell AW, Paranjpe S, Bowen WC, et al
    Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice.
    Hepatology. 2010;52:1060-7.
    PubMed     Text format     Related articles    Abstract available



  544. WONG F , Salerno F
    Beta-blockers in cirrhosis: Friend and foe?
    Hepatology. 2010;52:811-3.
    PubMed     Text format     Related articles   



  545. JI HF , Shen L
    On the mechanism of action of vitamin E for nonalcoholic steatohepatitis.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  546. FARRELL GC
    PNPLeAse get the fats right: does lipogenesis or lipolysis cause NASH?
    Hepatology. 2010;52:818-21.
    PubMed     Text format     Related articles   



  547. KOUTSARI C , Lazaridis KN
    Emerging genes associated with the progression of nonalcoholic fatty liver disease.
    Hepatology. 2010;52:807-10.
    PubMed     Text format     Related articles   



  548. ROTMAN Y , Koh C, Zmuda JM, Kleiner DE, et al
    The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.
    Hepatology. 2010;52:894-903.
    PubMed     Text format     Related articles    Abstract available



  549. SALAMONE F , Galvano F, Li Volti G
    Treating fatty liver for the prevention of cardiovascular diseases.
    Hepatology. 2010;52:1174-5.
    PubMed     Text format     Related articles   



  550. GHOURI N , Preiss D, Sattar N
    Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data.
    Hepatology. 2010;52:1156-61.
    PubMed     Text format     Related articles    Abstract available



  551. CHEN W , Chang B, Li L, Chan L, et al
    Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease.
    Hepatology. 2010;52:1134-42.
    PubMed     Text format     Related articles    Abstract available



  552. NEUSCHWANDER-TETRI BA , Clark JM, Bass NM, Van Natta ML, et al
    Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.
    Hepatology. 2010;52:913-24.
    PubMed     Text format     Related articles    Abstract available



  553. SPELIOTES EK , Butler JL, Palmer CD, Voight BF, et al
    PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.
    Hepatology. 2010;52:904-12.
    PubMed     Text format     Related articles    Abstract available



  554. TEIXEIRA-CLERC F , Belot MP, Manin S, Deveaux V, et al
    Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration.
    Hepatology. 2010;52:1046-59.
    PubMed     Text format     Related articles    Abstract available



  555. MIRANDA E , Perez J, Ekeowa UI, Hadzic N, et al
    A novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with alpha1-antitrypsin deficiency.
    Hepatology. 2010;52:1078-88.
    PubMed     Text format     Related articles    Abstract available



  556. KURINNA S , Stratton SA, Tsai WW, Akdemir KC, et al
    Direct activation of forkhead box O3 by tumor suppressors p53 and p73 is disrupted during liver regeneration in mice.
    Hepatology. 2010;52:1023-32.
    PubMed     Text format     Related articles    Abstract available



  557. DING W , You H, Dang H, LeBlanc F, et al
    Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion.
    Hepatology. 2010;52:945-53.
    PubMed     Text format     Related articles    Abstract available



  558. REMBACZ KP , Woudenberg J, Hoekstra M, Jonkers EZ, et al
    Unconjugated bile salts shuttle through hepatocyte peroxisomes for taurine conjugation.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  559. CHINNADURAI R , Grakoui A
    B7-H4 mediates inhibition of T cell responses by activated murine hepatic stellate cells.
    Hepatology. 2010 Sep 1:2178-2186.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  560. ORIA M , Chatauret N, Chavarria L, Romero-Gimenez J, et al
    Motor-evoked potentials in awake rats are a valid method of assessing hepatic encephalopathy and of studying its pathogenesis.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  561. XUE YH , Zhang XF, Dong QZ, Sun J, et al
    Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  562. FUJITA T
    Hepatectomy versus radiofrequency ablation for early-stage hepatocellular carcinoma1.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  563. GUPTE AA , Liu JZ, Ren Y, Minze LJ, et al
    Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  564. GOEPPERT B , Schmezer P, Dutruel C, Oakes C, et al
    Down-regulation of tumor suppressor a kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  565. QI F , Song J, Yang H, Gao W, et al
    Mmp23b promotes liver development and hepatocyte proliferation through the tumor necrosis factor pathway in zebrafish.
    Hepatology. 2010 Aug 31:2159-2167.
    PubMed     Text format     Related articles    Abstract available



  566. JAESCHKE H , Williams CD, Farhood A
    No evidence for caspase-dependent apoptosis in acetaminophen hepatotoxicity.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  567. VILLENEUVE J , Lepreux S, Mulot A, Berard AM, et al
    A protective role for CD154 in hepatic steatosis in mice.
    Hepatology. 2010 Aug 25:1969-1980.
    PubMed     Text format     Related articles    Abstract available



  568. LLACUNA L , Barcena C, Bellido-Martin L, Fernandez L, et al
    Growth arrest-specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  569. CHO IJ , Kim YW, Han CY, Kim EH, et al
    E-cadherin antagonizes transforming growth factor beta1 gene induction in hepatic stellate cells by inhibiting RhoA-dependent Smad3 phosphorylation.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  570. LENNERZ JK , Kuter DJ, Hasserjian R, Iafrate J, et al
    Massive hepatomegaly and involvement by Janus kinase 2-positive myeloproliferative neoplasm.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  571. KO KS , Tomasi ML, Iglesias-Ara A, French BA, et al
    Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  572. GOOSSENS N , Joshi D, O'Grady J
    Digital clubbing in association with hepatopulmonary syndrome.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  573. URBAN TJ , Thompson AJ, Bradrick SS, Fellay J, et al
    IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  574. MENG Z , Fu X, Chen X, Zeng S, et al
    miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  575. ZELLMER S , Schmidt-Heck W, Godoy P, Weng H, et al
    Transcription factors ETF, E2F, and SP-1 are involved in cytokine-independent proliferation of murine hepatocytes.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  576. WANG Y , Singh R, Xiang Y, Greenbaum LE, et al
    Nuclear factor kappaB up-regulation of CCAAT/enhancer-binding protein beta mediates hepatocyte resistance to tumor necrosis factor alpha toxicity.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  577. BELLOT P , Garcia-Pagan JC, Frances R, Abraldes JG, et al
    Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  578. CHEN K , Liu ML, Schaffer L, Li M, et al
    Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  579. YEH CT , So M, Ng J, Yang HW, et al
    Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  580. IAVARONE M , Sangiovanni A, Forzenigo LV, Massironi S, et al
    Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: The importance of tumor cell differentiation.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  581. EFE C , Purnak T, Ozaslan E
    The deleterious effects of propranolol on patients with cirrhosis.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  582. SHARMA D , Wang J, Fu PP, Sharma S, et al
    Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  583. SOLA E , Lens S, Guevara M, Martin-Llahi M, et al
    Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  584. SUBBIAH IM , Brown RE, Fallon MB
    Activation of the mammalian target of rapamycin signaling pathway in hepatocellular carcinoma.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  585. SIDDIQUE A , Kowdley K
    Gut instinct: Rifaximin for the prevention of hepatic encephalopathy.
    Hepatology. 2010;52:792-4.
    PubMed     Text format     Related articles   



  586. DUFOUR JF
    Vitamin E for nonalcoholic steatohepatitis: Ready for prime time?
    Hepatology. 2010;52:789-92.
    PubMed     Text format     Related articles   



  587. NEUSCHWANDER-TETRI BA
    Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites.
    Hepatology. 2010;52:774-88.
    PubMed     Text format     Related articles   



  588. HUANG W , Ding L, Huang Q, Hu H, et al
    Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma.
    Hepatology. 2010;52:703-14.
    PubMed     Text format     Related articles    Abstract available



  589. HU B , Colletti LM
    CXC receptor-2 knockout genotype increases X-linked inhibitor of apoptosis protein and protects mice from acetaminophen hepatotoxicity.
    Hepatology. 2010;52:691-702.
    PubMed